Common use of Protective Provisions Clause in Contracts

Protective Provisions. 7.1. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares, voting as a separate class: (a) any material change to the business scope, or nature of the business of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group Company; (b) any liquidation, dissolution or winding up of any Group Company, any consummation of a Liquidation Event or effecting any other merger or consolidation; (c) any sale, transfer, license, pledge or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, or any issuance, distribution, purchase or redemption of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (e) any amendment of Restated Articles or other charter documents of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares and the Series A Preferred Shares; (f) any change in share reserve under the ESOP (as defined in the Series B Share Purchase Agreement) or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (g) any approval of or adjustments or modification to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Shares; (i) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any of the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed above.

Appears in 3 contracts

Sources: Shareholder Agreements, Shareholder Agreement (Niu Technologies), Shareholder Agreement (Niu Technologies)

Protective Provisions. 7.1. In addition to such other limitations as may be provided in the Restated Articles, for so So long as any shares of Series A B Preferred Shares Stock are outstanding, the following acts of Company shall not without first obtaining the Group Companiesapproval (by vote or written consent, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not as provided by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval law) of the holders of at least two-thirds a sixty percent (2/360%) of the then outstanding shares of Series A B Preferred SharesStock, voting as a separate class: (a) create (by reclassification or otherwise) any material change new class or series of shares having rights, preferences or privileges equal or senior to the business scope, or nature of the business of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group CompanySeries B Preferred Stock; (b) any liquidationalter or change the rights, dissolution preferences or winding up privileges of any Group Company, any consummation of a Liquidation Event or effecting any other merger or consolidationthe Series B Preferred Stock; (c) any saleamend the Company’s Certificate of Incorporation in a manner that materially adversely affects the rights, transfer, license, pledge preferences or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted in privileges of the ordinary course holders of businessthe Series B Preferred Stock; (d) any increase, increase or decrease or cancellation the authorized number of any authorized or outstanding shares of any Group Preferred Stock of the Company, or any issuance, distribution, purchase or redemption of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (e) any amendment of Restated Articles liquidate or other charter documents of any Group Company which alters or adversely affects wind-up the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares and the Series A Preferred SharesCompany; (f) any change in share reserve under the ESOP (as defined in the Series B Share Purchase Agreement) or any other equity incentiveredeem, purchase or participation plan otherwise acquire (or pay into or set funds aside for a sinking fund for such purpose) any share or shares of Preferred Stock or Common Stock; provided, however, that this restriction shall not apply to the benefit repurchase of any shares of Common Stock from employees, officers, directors, contractorsconsultants or other persons performing services for the Company or any subsidiary pursuant to agreements under which the Company has the option to repurchase such shares at cost upon the occurrence of certain events, advisors such as the termination of employment, or consultants through the exercise of any right of the Group Companies; (g) any approval of or adjustments or modification to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Shares; (i) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any of the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentivesfirst refusal; or (g) take any other action by a Group Company (if applicable) which is required to authorize, approve be taken only with the consent or enter into any agreement or obligation with respect to any approval of the actions listed aboveholders of the Company’s capital stock, whether pursuant to the Certificate of Incorporation or the provisions of the Delaware General Corporation Law.

Appears in 3 contracts

Sources: Merger Agreement (Selena Pharmeceuticals Inc), Merger Agreement (Orion Acquisition Corp Ii), Merger Agreement (Orion Acquisition Corp Ii)

Protective Provisions. 7.1. (i) In addition to such other limitations as may be provided any requirements set forth in the Restated Articles, for so long as any Series A Preferred Shares are outstandingMemorandum and Articles or by the laws of the Cayman Islands, the following acts Company, Eastern Well and the PRC Companies shall not, and the Company and the Founder shall cause any Subsidiary not to (by way of shareholders resolutions, board resolutions or other means), take any of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require following actions without the prior written approval of the holders holder(s) of at least two-thirds (2/3) a majority of the then outstanding Series A A-1 Senior Preferred SharesShares (for the purpose of this Section, voting as a separate class:the term Company below shall also include the members of the Company Group): (a) Any action that authorizes, creates or issues any material change class of the Company securities having preferences superior to or on a parity with the Series A-1 Senior Preferred Shares or any other securities of the Company (other than with respect to the business scope, or nature of Series A-1 Option (as defined in the business of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group CompanyMemorandum and Articles)); (b) Any action that reclassifies any liquidation, dissolution outstanding shares into shares having preferences or winding up priority as to dividends or assets senior to or on a parity with the preference of any Group Company, any consummation of a Liquidation Event or effecting any other merger or consolidationthe Series A-1 Senior Preferred Shares; (c) Consolidation or merger with or into any saleother business entity, transferor the disposition of assets in excess of US$2,000,000 (individually or in the aggregate), license, pledge or encumbering the sale of the license out of all or substantially all substantial technology or of the Company’s intellectual property, other than non-exclusive licenses granted in the ordinary course of businessproperty rights; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, or any issuance, distribution, purchase or redemption of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant Any amendment to an equity incentive plan approved by the Board, including each Series A Director then in office, if any)Memorandum and Articles; (e) any Any amendment or change of Restated Articles or other charter documents of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B A-1 Senior Preferred Shares; (f) Any action that repurchases, redeems or retires any of the Company’s voting securities; (g) Approving the Company’s initial public offering, including selection of the listing exchange, any financial advisors, underwriters, or approval of the valuation and terms and conditions for a the Company’s initial public offering; (h) Approving or any form of merger or consolidation; (i) The liquidation or dissolution of the Company; (j) Any Liquidation Event; and (k) Issuance of debt over US$2,000,000 in a single transaction or series of related transactions. (ii) In addition to any requirements set forth in the Memorandum and Articles or by the laws of the Cayman Islands, the Company, Eastern Well and the PRC Companies shall not, and the Company and the Founder shall cause any Subsidiary not to (by way of shareholders resolutions, board resolutions or other means), take any of the following actions without the prior approval of the holder(s) of at least sixty-seven percent (67%) of the outstanding Series A Preferred Shares (for the purpose of this Section, the term Company below shall also include the members of the Company Group): (a) Any action that authorizes, creates or issues any class of the Company securities having preferences superior to or on a parity with the Series A Preferred Shares or any other securities of the Company (other than with respect to the Series A-1 Option); (b) Any action that reclassifies any outstanding shares into shares having preferences or priority as to dividends or assets senior to or on a parity with the preference of the Series A Preferred Shares; (c) Consolidation or merger with or into any other business entity, or the disposition of assets in excess of US$2,000,000 (individually or in the aggregate), or the sale of the license out of all or substantially all of the Company’s intellectual property rights; (d) Any amendment to the Memorandum and Articles of Association of the Company (other than amendments necessary to undergo the Company’s initial public offering approved under 10.7(i)(g) above); (e) Any amendment or change of the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series A Preferred Shares; (f) any change in share reserve under the ESOP (as defined in the Series B Share Purchase Agreement) Any action that repurchases, redeems or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of retires any of the Group CompaniesCompany’s voting securities; (g) any approval of or adjustments or modification to Approving the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any of the Group CompaniesCompany’s initial public offering, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Shares; (i) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any of the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination selection of the listing venueexchange, timingany financial advisors, underwriters, or approval of the valuation and other terms of and conditions for a the Company’s initial public offering; (lh) any acquisition of The liquidation or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any dissolution of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if anyCompany; (mi) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month periodAny Liquidation Event; orand (nj) any appointment, removal, replacement Issuance of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether debt over US$2,000,000 in a single transaction or series of related transactions. (iii) In addition to any requirements set forth in the Memorandum and Articles or by the laws of the Cayman Islands, whether directly the Company shall not, and the Company and the Founder shall cause any Subsidiary not to (by way of shareholders resolutions, board resolutions or indirectly and whether or not by amendmentother means), merger, consolidation, scheme take any of arrangement, amalgamation, or otherwise, shall require the following actions without the prior written approval by all Directors of the Board (of the Company, which approval includes shall include the approval affirmative vote of each a Series A Director then in officeand Series A-1 Director (for the purpose of this Section 10.7(iii), if any, whose approval the term Company below shall not be unreasonably withheld, delayed or conditionedalso include the members of the Company Group): (a) Making any loans by the Company to any Director, officer or employee outside the ordinary course of business consistent with past practices; (b) Declaration of dividends or other distributions and any changes in the dividend policy of the Company; (c) Adoption and implementation of the annual operating budget or strategic plans, which, once approved, shall not deviate from such operating budget or strategic plans; (d) Approval, adoption, amendment or administration of the ESOP; (e) Initiation and settlement of any material litigation where the amount claimed or in dispute exceeds US$500,000; (f) Any issuance of equity or debt securities of the Company (in a single transaction or a series of related transactions) (other than with respect to the Series A-1 Option); (g) Sale, mortgage, pledge, lease, transfer or otherwise disposition of any of the assets of the Company which are (i) outside the ordinary course of business, or (ii) in excess of US$500,000 in the aggregate over any twelve (12) months; (h) Approval or amendment of any quarterly and annual budget, business plan and operating plan (including any capital expenditure budget, operating budget and financing plan) of the Company; (i) Engaging in any business materially different from that described in the then current business plan, change of the name of the Company or ceasing any business undertaking of the Company; (j) Incurrence of any indebtedness or assumption of any financial obligation, or assumption, guarantee or creation of any liability for borrowed money in excess of US$500,000 in the aggregate at any time outstanding unless such liability is incurred pursuant to the then current business plan; (k) Any expenditure or other purchase of tangible or intangible assets in excess of US$1,000,000 in the aggregate over any twelve (12) months unless such expenditure or purchase is made pursuant to the then current business plan; (l) Entering into any material agreement or contract with any party or group of related parties under which the Company’s aggregate commitments, pledge or obligations to such party or group of related parties; (m) Any material change in the accounting methods or policies or appointment or change of the auditors, accounting policies, internal controls over financial reporting or auditors of the financial year of any Group Company; (bn) Disposition of or dilution of the Company’s interest, directly or indirectly, in any appointmentof its subsidiaries; (o) Appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for remuneration of the Chief Executive Officer, Chief Financial Officer, Chief Operating Officer, Vice President or General Manager of the Company and any share options or other equity incentivesmaterial subsidiaries of the Company; orand (gp) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any All accounts holding cash of the actions listed aboveCompany shall be established such that any expenditure exceeding RMB2,000,000, not relating to the core business or not included in the annual business plan of the Company, shall require the signature of each of the Series A-1 Director and the Series A Director. Such threshold may be adjusted with the consent of each of Series A-1 Director and each Series A Director, with written notice to the Company and such other documents as may be required by the applicable financial institutions. (iv) The Company is excluded from any obligation contained in this Agreement to the extent that such obligation would contain an unlawful ▇▇▇▇▇▇ on the Company’s statutory powers, provided that the Investors, the Founder and Wide Safety shall procure that the Company will perform all such obligations.

Appears in 2 contracts

Sources: Series a 1 Senior Preferred Share Purchase Agreement (Nobao Renewable Energy Holdings LTD), Shareholders Agreement (Nobao Renewable Energy Holdings LTD)

Protective Provisions. 7.1. In addition to such other limitations as may be provided in the Restated Articles, for so So long as any shares of Series A Preferred Shares are Stock shall be outstanding, the following acts Corporation shall not, without the approval by the vote or written consent of the Group CompaniesHolders of at least 66.6% (or more if required by law) of the then outstanding shares of Series A Stock: (a) Amend, whether waive or repeal any provisions of, or add any provision to, (i) this Certificate of Designation or (ii) any provision of the Corporation's Certificate of Incorporation or any other certificate of designation filed with the Secretary of State of Delaware by the Corporation with respect to its preferred stock; (b) Amend, waive or repeal any provisions of, or add any provision to, the Corporations By-Laws; (c) Authorize, create, issue or sell any shares of Equivalent Stock or Superior Stock; except as authorized in a single the Certificate of Designation (d) Issue any shares of Series A Stock other than pursuant to the Purchase Agreements or upon transfers of outstanding shares of Series A Stock; (e) Enter into any agreement, indenture or other instrument which contains any provisions restricting the Corporation's obligation to pay dividends on or make redemptions of the Series A Stock in accordance with Sections 4 and 5 hereof; (f) Consolidate with or merge into any other Person or permit any other Person to consolidate with or merge into it; (g) Sell, lease, encumber, transfer, liquidate or otherwise dispose of, in one transaction or a series of related transactions, whether directly all or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval substantially all of the holders of at least two-thirds (2/3) Assets of the then outstanding Series A Preferred Shares, voting as a separate class: (a) any material change to the business scope, or nature of the business of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group Company; (b) any liquidation, dissolution or winding up of any Group Company, any consummation of a Liquidation Event or effecting any other merger or consolidation; (c) any sale, transfer, license, pledge or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, or any issuance, distribution, purchase or redemption of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (e) any amendment of Restated Articles or other charter documents of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares and the Series A Preferred Shares; (f) any change in share reserve under the ESOP (as defined in the Series B Share Purchase Agreement) or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (g) any approval of or adjustments or modification to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Shares; (i) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any of the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month periodCorporation; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed above.

Appears in 2 contracts

Sources: Securities Purchase Agreement (Park N View Inc), Securities Purchase Agreement (Park N View Inc)

Protective Provisions. 7.1. In addition to such other limitations as may be provided in the Restated Articles, for so (a) So long as any Series A B Preferred Shares, Series B-1 Preferred Shares or Series B-2 Preferred Shares are outstanding, the following acts Company shall not, without first obtaining the approval by vote or written consent of the Group CompaniesBoard (including the approval of the Series B Directors, and, solely with respect to item (x) below, the director designated by the holders of Series A Preferred Shares): (i) redeem, repurchase, or acquire, directly or indirectly, any capital shares of the Company, other than repurchases of Ordinary Shares pursuant to Section 4.5 and the repurchases of Ordinary Shares issued to or held by officers, directors, employees or consultants providing services to the Company or any subsidiary, upon termination of services to the Company, pursuant to the Company’s standard provisions and at or below the original purchase price of such shares (“Termination Repurchases”); (ii) increase or decrease the number of Ordinary Shares authorized under the Company’s stock option plan; (iii) issue or grant any shares, options, or other securities of the Company or any of its subsidiaries to any Key Shareholder (as defined in the Memorandum and Articles of Association of the Company), whether in connection with an employment agreement or otherwise; (iv) approve any guarantee or agreement by the Company to indemnify any other person against any loss or liability, other than commercially reasonable warranties or indemnification granted to suppliers, customers and employees in the ordinary course of business; (v) grant any mortgage, pledge, hypothecation, or other security interest over all or substantially all of the Company’s assets or properties, whether tangible or intangible; (vi) enter into any purchase, lease, sale, or other transaction by the Company involving real property, except for a single lease or termination of a lease of reasonable commercial office space for use by the Company and/or its affiliates; (vii) borrow or incur indebtedness of the Company or its subsidiaries (including indebtedness in the form of the assumption or guaranty of indebtedness of any other person) which (A) is not in the ordinary course of business or in the business plan approved by the Board, or (B) cumulatively with all other borrowing, indebtedness of the Company in excess of $1,000,000 in the aggregate at any time; (viii) enter into any transaction or series of related transactionstransactions between the Company or any of its subsidiaries and any Key Shareholder (as defined in the Memorandum and Articles of Association of the Company), whether directly director, officer, employee, consultant or indirectly and whether affiliate of the Company (or any person related to or in which any director, officer, employee, consultant or affiliate of the Company holds a financial interest) (A) which involves a loan or advance of any kind (other than reasonable advances for travel expenses); (B) which is not in the ordinary course of business or in the most recent business plan approved by amendmentBoard; or (C) in which the aggregate value given or received exceeds $50,000 individually or $150,000 in the aggregate during any 12-month period; (ix) enter into any loan, merger, consolidation, scheme of arrangement, amalgamationadvance, or otherwiseextension of credit by the Company or its subsidiaries (A) not in the ordinary course of business or in the most recent business plan approved by the Board, shall require or (B) which cumulatively with all other loans and extensions of credit by the prior Companies exceeds $500,000 in the aggregate at any time; (x) appoint or remove the Chief Executive Officer, Chief Operating Officer, Managing Director, General Manager, Chief Financial Officer, or Chief Technology Officer of the Company, or increase the compensation of any of the five most highly compensated employees of the Company by more than 15% in any 12-month period (excluding, for purposes of this calculation, bonuses paid in accordance with the Company’s budget); (xi) change the auditors of the Company or any material accounting policy of the Company; (xii) delegate any authority in respect of any of the foregoing matters to any committee of the Board; (xiii) enter into any agreement, commitment, or corporate resolution to do any of the foregoing; (xiv) take any action that will in the good faith opinion of the Company’s counsel result in taxation of the holders of the Series B Preferred Shares, Series B-1 Preferred Shares or Series B-2 Preferred Shares under ▇▇▇▇▇▇▇ ▇▇▇ ▇▇ ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ Internal Revenue Code of 1986, as amended; or (xv) authorize and issue any securities of the Company in connection with any strategic transaction, corporate collaboration or legal settlement to which the Company is a party. (b) So long as any Series B Preferred Shares, Series B-1 Preferred Shares or Series B-2 Preferred Shares are outstanding, without first obtaining the approval by vote or written approval consent of the holders of at least two-thirds (2/3) of the sum of all of the then outstanding Series A B Preferred Shares, Series B-1 Preferred Shares and Series B-2 Preferred Shares, all of such series voting together as a separate classsingle class on an as-converted basis, the Company shall not, and will not permit any of its subsidiaries to: (ai) amend the Memorandum and Articles of Association of the Company or other constitutional documents of the Company; (ii) increase or decrease the authorized number of Preferred Shares, or amend or alter the rights, privileges and protections of the Series B Preferred Shares, the Series B-1 Preferred Shares or Series B-2 Preferred Shares; (iii) authorize, designate, reclassify or issue any shares or any equity securities convertible or exchangeable into shares ranking senior to or on parity with the Series B Preferred Shares, Series B-1 Preferred Shares or Series B-2 Preferred Shares with respect to liquidation, redemption, dividend rights and other rights, privileges and preferences of the Series B Preferred Shares, Series B-1 Preferred Shares or Series B-2 Preferred Shares; (iv) change the authorized number, manner of election, or term of office of Directors; (v) declare or pay any dividend or distribution on any shares or any equity security convertible or exchangeable into shares ranking junior to the Series B Preferred Shares, Series B-1 Preferred Shares or Series B-2 Preferred Shares in liquidation, redemption, or dividend rights or privileges; or redeem or repurchase any shares ranking junior to the Series B Preferred Shares, Series B-1 Preferred Shares or Series B-2 Preferred Shares in liquidation, redemption, or dividend rights or privileges except Termination Repurchases; (vi) enter into or agree to enter into any transaction or series of transactions that would constitute a Liquidation Event; (vii) approve any material change to the Company’s fundamental business scope, plan or nature strategy; or (viii) undertake or enter into any agreement to undertake an Initial Public Offering of Shares unless approved by a majority vote of the business Board of any Group Directors of the Company, engagement in or investment in any new line or business or sale, disposal or cessation which majority shall include at least one (1) of any existing business line of any Group Company; (b) any liquidation, dissolution or winding up of any Group Company, any consummation of a Liquidation Event or effecting any other merger or consolidation;the Series B Directors. (c) Without limiting any sale, transfer, license, pledge voting requirements or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, or any issuance, distribution, purchase or redemption of any shares, or securities convertible into or carrying a right of subscription in protections with respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (e) any amendment of Restated Articles or other charter documents of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares, Series B-1 Preferred Shares and the Series A B-2 Preferred Shares; (f) any change Shares above, in share reserve under the ESOP (as defined in the Series B Share Purchase Agreement) or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (g) any approval of or adjustments or modification addition to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Shares; (i) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any of the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the Board, the prior written consent of holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A B Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A B-1 Preferred Shares are outstandingand Series B-2 Preferred Shares, the following acts of the Group Companies, whether in all four series voting together as a single transaction class on an as-converted basis, is required to authorize or issue, or obligate the Company to authorize or issue, any new class or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval equity securities of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed Company or conditioned): (a) any appointment or change majority-owned subsidiary of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed above.

Appears in 2 contracts

Sources: Investor Rights Agreement (Montage Technology Group LTD), Investor Rights Agreement (Montage Technology Group LTD)

Protective Provisions. 7.110.1. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares or Class B Ordinary Shares (as applicable) are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, Company shall require the prior written approval of the holders of at least two-thirds Majority Holders, provided that notwithstanding anything to the contrary contained herein, where any act listed in clauses (2/3a) to (w) below requires a Special Resolution (as defined in the Restated Articles) of the then outstanding shareholders in accordance with the applicable Cayman law, and if the shareholders vote in favor of such act but the approval of the Majority Holder has not yet been obtained, the votes of the holders of the Series A Preferred SharesShares and the holders of Class B Ordinary Shares who vote against such act at a meeting of the shareholders shall be deemed to be equal to the votes of all the shareholders who vote in favor of such act plus one. For the purpose of this Section10, voting the term “Company” means, the Company itself as a separate class:well as any and all the subsidiaries of the Company (including but not limited to the other Group Companies), to the extent and where applicable. (a) any material amendment or change to the business scope, or nature of the business of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group Company; (b) any liquidation, dissolution or winding up of any Group Company, any consummation of a Liquidation Event or effecting any other merger or consolidation; (c) any sale, transfer, license, pledge or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, or any issuance, distribution, purchase or redemption of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (e) any amendment of Restated Articles or other charter documents of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, of the Series B Preferred Shares or Class B Ordinary Shares; any material change to the Memorandum and Articles of Association or other charter documents of the Company, or any other actions that would adversely affect the rights of the Preferred Shares or Class B Ordinary Shares; (b) any action that authorizes, creates or issues any class of the Company securities having preferences superior to or on a parity with the Preferred Shares or Class B Ordinary Shares or any other securities of the Company; (c) creating, authorizing, reclassifying, issuing, repurchasing or redeeming any equity securities of the Company, excluding (i) any issuance of Class A Ordinary Shares upon conversion of the Series A Preferred Shares or Class B Ordinary Shares, and (ii) the issuance of Class A Ordinary Shares (or options or warrants therefor) under employee equity incentive plans approved by the Board; (d) any consolidation, merger, corporate reorganization, transaction or series of transactions, in which in excess of fifty percent (50%) of the Company’s voting power is transferred or in which the whole or a substantial part of the intellectual properties or the assets of the Company and/or any Group Company is sold or licensed; the combination, division, liquidation, dissolution or winding up of the Company, or termination of the business of the Company in any other manner; (e) any change to the Memorandum and Articles of Association or other charter documents of the Company, or any decrease or increase in the share capital of the Company, change the organization form of the Company, cease to conduct its principal business substantially as now conducted by the Company or change any material part of its principal business; (f) any change in share reserve under the ESOP (as defined number of directors of the Company or in the Series B Share Purchase Agreement) or any other equity incentive, purchase or participation plan for manner in which the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companiesdirectors are appointed; (g) any approval of or adjustments or modification to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a any dividend or other distribution on any Ordinary Shares shares of the Company; settle or Preferred Sharesalter the terms of any profit sharing scheme or any employee share option or share participation schemes; make awards or grants to employees under any employee stock option plan or other similar incentive schemes; change any terms of liquidation preference; (h) appoint, remove or settle the terms of appointment or removal of the chief executive officer or chief financial officer/financial controller of the Company, pay the remuneration to the Founder; (i) appoint or change any merger, consolidation or amalgamation auditors of any Group Company with any other entity or entities or any spin-off, sub-divisionthe Company, or any other transaction of a similar nature or having a similar economic effect as any amend the accounting and financial policies of the foregoingCompany, or other forms change the fiscal year of restructuring the Company, or change the accounting firm of any Group the Company; (j) appoint, remove or settle the terms of appointment or removal of the chief operating officer, chief research officer, the chief technology officer, the chief marketing officer and any creationother management with a higher position of the Company; (k) acquire any investment or incur any commitment in excess of US$2,000,000 at any time in respect of any one transaction, authorization or issuance in excess of US$5,000,000 at any time in a series of transactions, in any financial year of the Company; (l) incurrence of any indebtedness other than the indebtedness in a commercial loan from any banks or other financial institutions out of the ordinary business course of the Company; (m) create or issue any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the undertaking, assets or rights of the Company except for the purpose of the commercial loans from any Group Company exceeding banks or other financial institutions in the ordinary course of business not in excess of US$1,000,000 (or its equivalent in another currency or other currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of a single transaction or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year a series of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if anytransactions; (mn) sell, transfer, license, charge, encumber or otherwise dispose of any trademarks, patents or other intellectual property owned by the Company; (o) any settlement action that approves the termination of the principal business of the Company, or alteration approves any consolidation, merger, corporate reorganization and liquidation of the Company, or appoints or removes the successors, managers, legal managers or other similar personnel; (p) any transaction or series of transactions between the Company and any shareholder, director, officer or employee of the Company, or any affiliate of any employment agreementshareholder of the Company or any of its officers, salariesdirectors or shareholders, bonuses or other incentive plans of any key management (including but not limited to the Key Employees extension by the Company of any loan or guarantee for any indebtedness to such persons (as defined excluding the transactions with Red Better and/or its affiliates); (q) make any equity investment in any other companies or establish a new brand for any other entities than the Group Companies; (r) any disposal or dilution of the equity interest directly or indirectly held by the Company in any other entities or companies; (s) any action that approves the sale, transfer of any equity interest (excluding the Preferred Shares and shares held by the Series A Investors or their nominees and the Class B Ordinary Shares and shares held by Red Better and Shunwei or their nominees) of the Company; (t) any adoption or material amendment of the Company’s business plan or budget or, or conduct any transaction in excess of such approved budget or business plan; (u) the increase in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group the five (5) most highly compensated employees of the Company by more than US$200,000 fifty percent (50%) in a twelve (12) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (bv) any appointment, removal, replacement other material event of the chief executive officer, Company as the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer Investors and the chief operating officer of any Group Company, including approving any option plans;Founder jointly present; and (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (gw) any action by a Group the Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed above.

Appears in 2 contracts

Sources: Shareholders Agreement (Viomi Technology Co., LTD), Shareholders Agreement (Viomi Technology Co., LTD)

Protective Provisions. 7.1. In Notwithstanding any other provision of this Agreement and to the fullest extent permitted by applicable law, in addition to such other limitations the approval of the Directors, the following actions described in this Section 3(a) (collectively, the “Consent Matters”) shall require the prior written consent of Apax Partners and/or WCAS as may set out below: i. none of the following actions shall be provided taken by the Company, including any proposal by the Board to be put to the vote of the stockholders of the Company with respect thereto, without (A) the prior written consent of Apax Partners for so long as Apax Partners owns at least 5% of the Original Amount and (B) the prior written consent of WCAS for so long as WCAS owns at least 5% of the Original Amount (except as set forth in the proviso in Section 3(a)(I)): I. amending, altering or changing, or waiving any rights under, this Agreement, the organizational documents, including the Amended and Restated ArticlesCertificate of Incorporation or the Bylaws of the Company, (which shall also be subject to Section 5) and/or the organizational documents of any subsidiary of the Company; provided that, notwithstanding the foregoing, for so long as Apax Partners or WCAS, as applicable, own any Series A Preferred Shares outstanding Common Stock, any amendment, alteration, or change to, or waiver under, other organizational documents, including the Amended and Restated Certificate of Incorporation or the Bylaws of the Company, and/or the organizational documents of any subsidiary of the Company that would adversely affect in any respect any rights specific to Apax Partners or WCAS shall (subject to applicable law) require the written consent of Apax Partners or WCAS, as applicable; II. authorizing or issuing any equity securities of the Company having rights, preferences or privileges that are outstanding, superior or senior to the outstanding Common Stock (or any securities convertible or exchangeable therefor pursuant to their terms); III. any transaction with any stockholder or Affiliate of a stockholder or any Director or officer of the Company or any of its subsidiaries (other than employment agreements with officers not otherwise affiliated with a stockholder); IV. winding up the Company; and V. entering into any agreement with respect to the matters described in the foregoing clauses (I) through (IV) or taking any such action indirectly. ii. none of the following acts actions shall be taken by the Company, including any proposal by the Board to be put to the vote of the Group Companiesstockholders of the Company with respect thereto, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require without (A) the prior written approval consent of Apax Partners for so long as Apax Partners owns at least 20% of the holders Original Amount and (B) the prior written consent of WCAS for so long as WCAS owns at least two-thirds (2/3) 20% of the then outstanding Series A Preferred Shares, voting as a separate classOriginal Amount: (a) any material change to I. the business scope, declaration or nature of the business payment of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group Company; (b) any liquidation, dissolution or winding up of any Group Company, any consummation of a Liquidation Event or effecting any other merger or consolidation; (c) any sale, transfer, license, pledge or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, or any issuance, distribution, purchase or redemption of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (e) any amendment of Restated Articles or other charter documents of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares and the Series A Preferred Shares; (f) any change in share reserve under the ESOP (as defined in the Series B Share Purchase Agreement) or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (g) any approval of or adjustments or modification to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Shares to the stockholders by the Company or Preferred Shares; redemption, repurchase or exchange (ias applicable) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any of the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of the Company; II. issuing or granting any Group Company; determination equity securities of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (Company or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companiessubsidiaries, other than pursuant to grants under the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if anyCompany’s 2021 Omnibus Incentive Plan; (m) III. engaging in any settlement mergers, acquisitions, business combinations or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment similar transactions or entering into any arrangements or agreements relating to joint venture ventures or strategic partnerships with any person;a value of such transaction or arrangement exceeding $10.0 million; and (e) IV. entry by the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to the matters described in the foregoing clauses (I) through (III) or taking any of the actions listed abovesuch action indirectly.

Appears in 2 contracts

Sources: Director Nomination Agreement (InnovAge Holding Corp.), Director Nomination Agreement (InnovAge Holding Corp.)

Protective Provisions. 7.1. In addition Subject to such other limitations as the rights of series or classes of Preferred Stock which may be provided from time to time come into existence in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, accordance with the following acts of Protective Provisions, this Company shall not without first obtaining the Group Companiesapproval (by vote or written consent, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not as provided by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval law) of the holders of at least two-thirds (66 2/3) % of the then outstanding shares of Series A Preferred Shares, Stock voting as a separate class: (a) any material change to the business scopea. sell, convey, or nature otherwise dispose of the business all or substantially all of any Group Company, engagement in or investment in any new line its property or business or salemerge into or consolidate with any other company (other than a wholly-owned subsidiary company) or effect any other transaction or series of related transactions in which more than fifty percent (50%) of the voting power of the Company is disposed of, disposal or cessation provided that this Section 6(a) shall not apply to a merger effected exclusively for the purpose of any existing business line changing the domicile of any Group the Company; (b) any liquidation, dissolution b. amend or winding up modify the Restated Certificate of any Group Incorporation or Bylaws of the Company, any consummation of a Liquidation Event or effecting any other merger or consolidation; (c) any sale, transfer, license, pledge c. amend or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, or any issuance, distribution, purchase or redemption of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (e) any amendment of Restated Articles or other charter documents of any Group Company which alters or adversely affects change the rights, preferences, preferences or privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares and of the Series A Preferred SharesStock; (f) any change in share reserve under the ESOP (as defined in the Series B Share Purchase Agreement) d. authorize or issue, or obligate itself to issue, any other equity incentivesecurity, including any other security convertible into or exercisable for any equity security, having a preference over, or being on a parity with, the Series A Preferred Stock with respect to voting, dividends or upon liquidation; e. redeem, purchase or participation plan otherwise acquire (or pay into or set funds aside for a sinking fund for such purpose) any share or shares of Preferred Stock or Common Stock; provided, however, that this restriction shall not apply to the benefit repurchase of any shares of Common Stock from employees, officers, directors, contractorsconsultants or other persons performing services for the Company or any subsidiary pursuant to agreements under which the Company has the option to repurchase such shares at cost or at cost upon the occurrence of certain events, advisors such as the termination of employment; f. increase or consultants decrease the authorized Preferred Stock; g. reclassify or recapitalize the capital stock of the Company; h. effect the liquidation of the Company; or i. issue (directly or pursuant to the exercise of any option) or authorize or reserve for issuance to employees, consultants and directors as equity incentive compensation in excess of 2,500,000 shares of Common Stock, whether or not pursuant to a benefit plan, and taking into account all such shares that have been so issued, authorized or reserved as of the Group Companies; (g) any approval ▇▇▇▇ of or adjustments or modification to filing of this Restated Certificate of Incorporation. In addition, the terms consent of any transaction involving the interest of any director, employee, officer, management member or shareholder of any 66 2/3 % of the Group CompaniesSeries A Preferred Stock, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security shall be required for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Shares; (i) any mergeradversely effects the rights, consolidation preferences or amalgamation privileges of any Group Company with the Series A Preferred Stock in a manner different from that of other classes of Preferred Stock that might be created, (if) creates or is likely to create a conflict of interest between the Series A Preferred Stock and any other entity class of Preferred Stock that might be created, or entities (iii) creates a class or any spin-off, sub-division, series of stock or any other transaction of a similar nature or having a similar economic effect as any of the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any securities convertible into equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of Company having a preference over the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred SharesStock. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed above.

Appears in 2 contracts

Sources: Preferred Stock Purchase Warrant (Bayhill Therapeutics, Inc.), Warrant Agreement (Bayhill Therapeutics, Inc.)

Protective Provisions. 7.1. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares, voting as a separate class: (a) any material change The parties hereto agree that the Company and its Subsidiaries shall have the right to the business scope, or nature of the business of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group Company; (b) any liquidation, dissolution or winding up of any Group Company, any consummation of a Liquidation Event or effecting any other merger or consolidation; (c) any sale, transfer, terminate their intellectual property and license, pledge sub-license or encumbering all or all substantial technology or contribute their intellectual property, property to third parties other than non-exclusive licenses granted the Fortress Shareholders (any such transaction, an “IP Transaction”) in the ordinary course of business; (d) business pursuant to any increaseresearch and development, decrease or cancellation of any authorized or outstanding shares of any Group Companycollaboration, or any issuanceconsortium, joint development, distribution, purchase service, joint marketing, co-branding or redemption co-distribution agreement or other similar agreements or arrangements entered into in the ordinary course of business and in a manner consistent with market practice for the industry of the Company; provided that, until such time as the Fortress Shareholders own in the aggregate less than 10% of the then outstanding Ordinary Shares (including Ordinary Shares underlying American Depositary Shares) for more than [***], any sharesDartmouth IP Transaction shall be subject to approval by the Board of Directors, including the vote of at least one Fortress Designee. (b) Until such time as the Fortress Shareholders own in the aggregate less than 10% of the then outstanding Ordinary Shares (including Ordinary Shares underlying American Depositary Shares) for a period of more than [***], the Company and its Subsidiaries shall not, directly or securities convertible into indirectly, without the consent of each Shareholder, (i) incur or carrying a right issue any indebtedness that would encumber any intellectual property of subscription in respect of any shares the Company or any warrant or of its Subsidiaries, (ii) issue any grant or issuance Equity Securities of options the Company that are senior to the Ordinary Shares with respect to the right to receive (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (ex) any amendment of Restated Articles dividends or other charter documents distributions to shareholders or (y) proceeds in the event of the liquidation, dissolution or winding-up of the Company (including for such purposes in connection with any Group Company which alters change of control transaction), (iii) alter, amend or adversely affects change the rights, preferences, preference or privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares and the Series A Preferred Shares; (f) any change in share reserve under the ESOP (as defined in the Series B Share Purchase Agreement) or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (g) any approval of or adjustments or modification to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any of the Group CompaniesOrdinary Shares, including but not limited to the making of in connection with any loans reclassification, recapitalization, reorganization or advancesrestructuring, whether (iv) recommend, directly or indirectly, or take any other action to (A) increase or decrease the size of the Board of Directors or (B) co-opt or appoint to the Board of Directors in place of a Fortress Designee any Person other than a Fortress Designee, (v) make any proposal to amend, repeal or otherwise modify any provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities the Company’s articles of association that would be reasonably expected to adversely affect the interests of any director, employee, officer, management member Fortress Shareholder or shareholder of (vi) make any proposal to modify the Group Companies; (h) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Shares; (i) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any of the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination Equity Securities of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect manner adverse to any of the actions listed aboveShareholder.

Appears in 2 contracts

Sources: Shareholders’ Rights Agreement (Fortress Investment Group LLC), Shareholders’ Rights Agreement (Fortress Investment Group LLC)

Protective Provisions. 7.1. In addition Subject to such other limitations as the rights of Series of Preferred Stock which may be provided in the Restated Articlesfrom time to time come into existence, for so long as any shares of Series A Preferred Shares Stock are outstanding, the following acts of Corporation shall not without first obtaining the Group Companiesapproval (by vote or written consent, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not as provided by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval law) of the holders of at least two-thirds (2/3) a majority of the then outstanding shares of Series A Preferred Shares, voting as a separate classStock: (a) any material change to the business scopesell, convey, or nature otherwise dispose of the business or encumber all or substantially all of any Group Company, engagement in or investment in any new line its property or business or sale, disposal merge into or cessation consolidate with any other corporation (other than a wholly-owned subsidiary corporation) or effect any transaction or Series of any existing business line related transactions in which more than fifty percent (50%) of any Group Companythe voting power of the corporation is disposed of; (b) any liquidationalter or change the rights, dissolution preferences or winding up privileges of any Group Company, any consummation the shares of a Liquidation Event or effecting any other merger or consolidationSeries A Preferred Stock so as to affect adversely the shares; (c) any sale, transfer, license, pledge increase or encumbering all or all substantial technology or intellectual property, decrease (other than non-exclusive licenses granted in by redemption or conversion) the ordinary course total number of businessauthorized shares of Series A Preferred Stock; (d) any increase, decrease authorize or cancellation of any authorized or outstanding shares of any Group Companyissue, or obligate itself to issue, any issuanceother equity security, distribution, purchase or redemption of including any shares, or securities other security convertible into or carrying exercisable for any equity security (i) having a right of subscription in respect of any shares preference over, or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by being on a parity with, the Board, including each Series A Director then in officePreferred Stock with respect to voting, if any);dividends or upon liquidation, or (ii) having rights similar to any of the rights of the Series A Preferred Stock under this Section 6; or (e) any amendment of Restated Articles or other charter documents of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares and the Series A Preferred Shares; (f) any change in share reserve under the ESOP (as defined in the Series B Share Purchase Agreement) or any other equity incentiveredeem, purchase or participation plan otherwise acquire (or pay into or set aside for a sinking fund for such purpose) any share or shares of Preferred Stock or Common Stock; provided, however, that this restriction shall not apply to (i) the benefit repurchase of any shares of Common Stock from employees, officers, directors, contractorsconsultants or other persons performing services for the Company or any subsidiary pursuant to agreements under which the Company has the option to repurchase such shares at cost or at cost upon the occurrence of certain events, advisors or consultants such as the termination of any of employment provided further, however, that the Group Companies; (g) any approval of or adjustments or modification total amount applied to the terms repurchase of shares of Common Stock shall not exceed $100,000 during any transaction involving the interest of any director, employee, officer, management member or shareholder of any of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Shares; (i) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any of the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month periodperiod or (ii) the redemption of any share or shares of Preferred Stock otherwise than by redemption in accordance with Section 4; or (nf) issue any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution dividends with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment respect to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentivesCorporation’s Common Stock; or (g) any action by a Group Company amend the Corporation’s Certificate of Incorporation or bylaws; or (if applicableh) to authorize, approve or enter into any agreement or obligation with respect to any change the authorized number of directors of the actions listed abovecorporation.

Appears in 2 contracts

Sources: Merger Agreement (International Microcomputer Software Inc /Ca/), Joint Operating Agreement (International Microcomputer Software Inc /Ca/)

Protective Provisions. 7.1. In addition to such other limitations as may be provided in the Restated Articles, for so long as The Company shall not take any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require --------------------- following actions without the prior affirmative written approval consent of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred C Shares, voting as a separate class: (a) alter, change or amend (by merger or otherwise) any material change to the business scope, or nature of the business rights, preferences or privileges of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group Companythe Series C Shares; (b) other than as provided in Section 5(c) of the Certificate of Designation of Rights, Preferences and Limitations of the Company's Series B Preferred Stock, amend, restate, alter, modify or repeal (by merger or otherwise) the Articles of Incorporation or the Bylaws of the Company, including, without limitation, amending, restating, modifying or repealing (by merger or otherwise) (i) any liquidationcertificate of designation or preferences (as in effect from time to time) relating to any series of preferred stock or (ii) any of the rights, dissolution or winding up preferences and privileges of any Group Companyother class of capital stock, or the terms or provisions of any consummation of a Liquidation Event option or effecting any other merger or consolidationconvertible security; (ci) create, authorize or issue any sale, transfer, license, pledge securities or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, such class or any issuance, distribution, purchase series of securities which rank senior to or redemption of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (e) any amendment of Restated Articles or other charter documents of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, on parity with the Series B Preferred Shares and the Series A Preferred C Shares; (fii) create, authorize or issue any change in share reserve under the ESOP (as defined in the Series B Share Purchase Agreement) securities or any other equity incentive, purchase or participation plan for the benefit shares of any employeessuch class or series of securities the holders of which have the right to cast more than one vote per share, officersand/or have the right, directorsvoting as a class or series, contractorsto elect one or more members of the Board of Directors; (iii) create, advisors authorize or consultants issue any securities or shares of any such class or series of securities convertible into, or exercisable, redeemable or exchangeable for, shares of any of the Group Companies; foregoing; (giv) any approval increase or decrease the authorized number of or adjustments or modification to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder shares of any of the Group Companies, including but not limited to foregoing; or (v) increase or decrease the making authorized number of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Series C Shares; (i) initiate or suffer to exist any mergerLiquidation Event with respect to the Company, (ii) enter into any merger or consolidation or amalgamation of any Group Company with any other entity Person that results in the holders of the Company's capital stock immediately prior to such transaction owning less than fifty percent (50%) of the voting power of the successor entity's capital stock after such transaction or entities (iii) otherwise discontinue or any spin-offdispose of more than ten percent (10%) of the assets of the business of the Company, sub-divisiontaken as a whole. For purposes of this Section 5, or any other transaction of a similar nature or having a similar economic effect as "Liquidation Event" shall mean any of the foregoingfollowing events: (i) the commencement by the Company of a voluntary case under the bankruptcy laws of the United States, as now or hereafter in effect, or other forms the commencement of restructuring an involuntary case against the Company, which petition shall not be opposed within fifteen (15) days or be dismissed within sixty (60) days after commencement thereof; (ii) the appointment of a custodian for, or the taking charge by a custodian of, all or substantially all of the property of the Company; (iii) the commencement by the Company or on its behalf or with its consent of any Group Company; (j) proceeding under any creationreorganization, authorization arrangement, adjustment of debt, relief of debtors, dissolution, insolvency or issuance liquidation or similar law of any debenture constituting jurisdiction whether now or hereafter in effect; (iv) the commencement by anyone without the Company's consent of any proceeding of the type set forth in the preceding clause (iii) which is not controverted within fifteen (15) days thereof and dismissed within sixty (60) days after the commencement thereof; (v) the adjudication of the Company as insolvent or bankrupt, or the adoption by the Company of a pledgeplan of liquidation, lien (vi) the occurrence of any Change of Control; or charge (whether by way vii) the filing of fixed or floating charge, mortgage encumbrance or other security) a certificate of dissolution on all or behalf of the Company with the Secretary of State of the State of Minnesota; in any of the assets cases (i) through (vi) above, in a single transaction or rights series of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering related transactions. For purposes of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)this Section 5(d), a "Change of Control" shall be deemed to have occurred upon (i) the consummation of a tender for or any change in compensation purchase of any employee of any Group Company by more than US$200,000 in a twelve fifty percent (12) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/350%) of the then outstanding Series A Preferred Shares has not been obtained, then Company's Common Stock by a third party other than the holders holder of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting majority of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated ArticlesC Stock, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require (ii) any other transaction such that the prior written approval shareholders of the Board Company immediately prior to the consummation of such transaction possess less than fifty percent (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a50%) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement voting securities of the chief executive officersurviving or continuing entity immediately after the transaction, in a single transaction or a series of related transactions unless such transactions have been approved by the president, vote of all directors elected or designated by the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any holders of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed aboveSeries B Preferred Stock.

Appears in 2 contracts

Sources: Preferred Stock Purchase Agreement (Fieldworks Inc), Preferred Stock Purchase Agreement (Fieldworks Inc)

Protective Provisions. 7.1. In Notwithstanding any other provision of this Agreement and to the fullest extent permitted by applicable law, in addition to such other limitations the approval of the Directors, the following actions described in this Section 3(a) (collectively, the “Consent Matters”) shall require the prior written consent of the Accenture Investors and/or the Apax Investor as may set out below: (i) none of the following actions shall be provided taken by the Company, including any proposal by the Board to be put to the vote of the Stockholders of the Company with respect thereto, without (A) the prior written consent of the Accenture Investors for so long as they collectively own at least 5.0% of the outstanding Equity Securities that are not Restricted Shares and (B) the prior written consent of the Apax Investor for so long as it owns at least 5.0% of the outstanding Equity Securities that are not Restricted Shares (except as set forth in the Restated Articlesproviso in Section 3(a)(i)(1)): (1) amending, altering or changing, or waiving any rights under, this Agreement, the organizational documents, including the Certificate of Incorporation or the Bylaws of the Company, (which shall also be subject to Section 8(f)) and/or the organizational documents of any Subsidiary of the Company; provided, that, notwithstanding the foregoing, for so long as the Accenture Investors or Apax Investor, as applicable, own any Series A Preferred Shares are outstandingoutstanding Equity Securities, any amendment, alteration, or change to, or waiver under, other organizational documents, including the following acts Certificate of Incorporation or the Bylaws of the Group CompaniesCompany, whether and/or the organizational documents of any Subsidiary of the Company that would adversely affect in a single transaction any respect any rights specific to the Accenture Investors or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, Apax Investor shall (subject to applicable law) require the prior written approval consent of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred SharesAccenture Investors or Apax Investor, voting as a separate class: (a) any material change to the business scope, or nature of the business of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group Companyapplicable; (b2) authorizing or issuing any liquidationEquity Securities of the Company having rights, dissolution preferences or winding up of any Group Company, any consummation of a Liquidation Event privileges that are superior or effecting any other merger or consolidation; senior to the outstanding Common Stock (c) any sale, transfer, license, pledge or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, or any issuance, distribution, purchase or redemption of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than exchangeable therefor pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if anytheir terms); (e3) any amendment transaction with any Stockholder or Affiliate of Restated Articles a Stockholder or any director or officer of the Company or any of its Subsidiaries (other charter documents of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares than employment agreements with officers not otherwise affiliated with a Stockholder and the Series A Preferred SharesAlliance Agreement); (f4) any change in share reserve under the ESOP (as defined in the Series B Share Purchase Agreement) Company or any other equity incentiveof its Subsidiaries entering into any line of business outside of (A) providing software, purchase or participation plan for computer programs and applications to clients and performing services with respect to such software, computer programs and applications and (B) performing services with respect to related third-party software, computer programs and applications of such clients as is required in connection with the benefit performance of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companiesservices to such clients; (g5) any approval of or adjustments or modification to changing the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any entity classification of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Shares; (i) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any of the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of its Subsidiaries or otherwise entering into any restructuring transaction, in each case, if such action would adversely change the assets or rights tax treatment of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) the Accenture Investors’ investment in the aggregate Company, as applicable, or otherwise result in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant adverse tax consequences to the annual budget Accenture Group (and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval consent shall not be unreasonably withheld, delayed conditioned or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Companydelayed); (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed above.

Appears in 2 contracts

Sources: Stockholders Agreement (Duck Creek Technologies, Inc.), Stockholders Agreement (Duck Creek Technologies, Inc.)

Protective Provisions. 7.1. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstandingMemorandum and Articles and the BVI Business Companies ▇▇▇ ▇▇▇▇, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, Company shall require the prior written approval of the holders holder(s) of at least twoseventy-thirds five percent (2/375%) of the then outstanding Series A Preferred Shares, voting as ; provided that such requirement shall terminate upon a separate classQualified Public Offering: (a) any material change to the business scope, or nature of the business of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group Company; (b) any liquidation, dissolution or winding up of any Group Company, any consummation of a Liquidation Event or effecting any other merger or consolidation; (c) any sale, transfer, license, pledge or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, or any issuance, distribution, purchase or redemption of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (ei) any amendment or change of Restated Articles or other charter documents of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred A Shares and of the Company; (ii) any action to authorize, create or issue shares of any class or series of the Company having preferences superior to or on a parity with the Series A Preferred Shares in any aspects including without limitation dividend rights, redemption rights and/or liquidation rights; (iii) any new issuance of any equity securities of the Company, excluding (i) any issuance of the Series A Shares under the Purchase Agreement, (ii) any issuance of Ordinary Shares upon conversion of the Series A Shares, and (iii) the issuance of up to 66.58 Ordinary Shares (or options or warrants therefor) under employee equity incentive plans approved by the Board and the Investors; (iv) any action of the Company to reclassify any outstanding shares into shares having preferences or priority as to dividends or assets senior to or on a parity with the preference of the Series A Shares; (fv) any change in share reserve under increase or decrease of the ESOP authorized number of Ordinary Shares or Series A Shares of the Company; (vi) any repurchase or redemption of any equity securities of the Company other than pursuant to (A) the redemption right of the holders of Series A Shares as defined provided in the Series B Share Purchase AgreementMemorandum and Articles, or (B) or any other equity incentive, purchase or participation plan for contractual rights to repurchase Ordinary Shares from the benefit of any employees, officers, directors, contractors, advisors directors or consultants of any the Company upon termination of their employment or services or pursuant to a contractual right of first refusal held by the Group CompaniesCompany; (gvii) any approval of or adjustments or modification to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any amendment of the Group Companies, including but not limited to the making Memorandum and Articles of any loans Association or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder other charter documents of the Group CompaniesCompany (including any Major Subsidiary); (hviii) any action that results merger or consolidation of the Company (including any Subsidiary) with or into any other business entity in which the shareholders of the Company (including any Subsidiary) immediately after such merger or consolidation held shares representing less than a majority of the voting power of the outstanding share capital of the surviving business entity; (ix) the sale, lease, transfer or other disposition of all or substantially all of the assets of the Company (including any Subsidiary), except for intra-group transactions among the Company and any Subsidiaries; (x) any licensing or otherwise transfer of the patents, copyrights, trademarks or other intellectual property of the Company (including any Subsidiary) other than in the ordinary course of its business, except for intra-group transactions among the Company and any Subsidiaries; (xi) any increase or decrease of the authorized number of the board members of the Company; (xii) the liquidation, dissolution or winding up of the Company (including any Subsidiary); (xiii) the declaration or payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Shares; (i) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any Series A Shares of the foregoing, or other forms of restructuring of any Group Company; (jxiv) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any increase of the assets or rights number of Ordinary Shares of the Company reserved under any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Companyemployee equity incentive plan; (kxv) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change increase in compensation of any employee of the Company (including any Group Company Subsidiary) with an annual salary of US$50,000 or more by more than US$200,000 twenty percent (20%) in a twelve (12) month period; (xvi) the extension by the Company of any loan or guarantee for indebtedness to any director, officer, employee or affiliate of the Company (including any Subsidiary), except for intra-group transactions among the Company and any Subsidiaries; (xvii) any incurrence of indebtedness in excess of US$300,000 in the aggregate to the Company (including any Subsidiary), or creation of any encumbrance whatsoever upon the assets, patents, copyrights, trademarks or other intellectual property of the Company (including any Subsidiary); (xviii) any purchase by the Company (including any Subsidiary) of real property with a value of US$300,000 or more, or any purchase of production facilities with a value of US$500,000 or more, individually or in the aggregate; (xix) any transaction or series of transactions that are not in the ordinary course of the Company’s business where the value involved exceeds US$300,000, individually or in the aggregate, during any twelve (12) month period; (xx) approval of the annual consolidated budget of the Company; or (nxxi) the appointment and removal of any appointment, removal, replacement key officer of the directors Company (including any Major Subsidiary), including the Chief Executive Officer and the Chief Financial Officer; (xxii) the appointment and/or reappointment of any Group Company; For the avoidance of doubt, if any auditors of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (bxxiii) any appointment, removal, replacement of transaction involving both the chief executive officer, the president, the chief financial officer Company (including any Subsidiary) and a shareholder or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any Company’s employees, officers, directors, contractors, advisors directors or consultants shareholders or any affiliate of a shareholder or any of its officers, directors or shareholders, except for intra-group transactions among the Group Companies; (f) the determination of the exercise price for Company and any share options or other equity incentivesSubsidiaries; or (gxxiv) any action by a Group items of capital expenditure outside the annual budget of the Company (if applicableincluding any Subsidiary) to authorizein excess of US$150,000 per month, approve individually or enter into any agreement or obligation with respect to any of in the actions listed aboveaggregate.

Appears in 1 contract

Sources: Series a Preferred Share Purchase Agreement (Le Gaga Holdings LTD)

Protective Provisions. 7.1. 9.1 In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, Company (whether in a single transaction or a series of related transactions, and whether directly or indirectly and whether indirectly, or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, ) shall require the prior written approval of the holders Majority Preferred Holders. For the purpose of at least two-thirds (2/3) this Section 9, the term “Company” means, the Company itself as well as any and all the subsidiaries of the then outstanding Series A Preferred SharesCompany (including but not limited to the other Group Companies), voting as a separate class:to the extent and where applicable. (a) create, issue, or increase the authorized or designated number of, any material change shares or any other securities convertible into equity securities of the Company having rights, preferences or privileges on parity with or senior to the business scopeSeries E Preferred Shares including but not limited to liquidation, redemption or nature of the business of any Group Company, engagement in dividend rights or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group Companyprivileges; (b) any liquidationaction that increases, dissolution reduces or winding up cancels the authorized number of any Group class or series of shares of the Company, any consummation or the number of a Liquidation Event or effecting any other merger or consolidation; (c) any sale, transfer, license, pledge or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares issued share capital of any Group Company, or that authorizes, creates, issues, or repurchases, redeems, or retires any issuance, distribution, purchase or redemption of any shares, shares or securities convertible into or carrying a right of subscription in respect of any shares or any warrant share warrants except for any issuance under the ESOP or any grant or issuance of options (other than repurchase pursuant to an equity incentive plan approved this Agreement, the Restricted Share Agreement or the Restated Articles; (c) any filing by or against any Group Company for the Boardappointment of a receiver, including each Series A Director then in officeadministrator or other form of external manager, if any)or the winding up, liquidation, bankruptcy or insolvency of any Group Company; or a Trade Sale; (d) pay or declare any dividend or make any distribution of dividends or other distributions solely on any Ordinary Shares; (e) any change in the maximum number of directors of the Company, or any variation of any rights or privileges enjoyed by the Board under this Agreement and the Restated Articles; (f) approval, amendment or termination of the ESOP; and (g) any amendment or change of the Restated Articles or other charter documents of any Group Company which alters or adversely affects the rights, preferences, privileges or powers ofof Preferred Shares, or the restrictions provided which for the benefit ofavoidance of doubt, shall not include any amendment or change of the Restated Articles necessary for or as a result of actions approved pursuant to other items under this Section 9. Notwithstanding anything to the contrary contained herein, if the shareholders of the Company voted in favor of such act listed in clause (a) to (g) above, but the Majority Preferred Holders have voted against any such act, such Majority Preferred Holders who voted against such act shall carry the number of votes equal to such votes held by all shareholders of the Company who voted in favor of such resolution plus one (1). 9.2 In addition to such other limitations as may be provided in the Restated Articles, (a) any disproportionate or unfair change of rights, privileges and preference of the Series B Seed Preferred Shares entitled by the holders of the Series Seed Preferred Shares under the Transaction Documents shall require the prior written consent of the Majority Series Seed Preferred Holders; (b) any disproportionate or unfair change of rights, privileges and preference of the Series A Preferred SharesShares entitled by the holders of the Series A Preferred Shares under the Transaction Documents shall require the prior written consent of the Majority Series A Preferred Holders; (c) any disproportionate or unfair change of rights, privileges and preference of the Series B-1 Preferred Shares and Series B-2 Preferred Shares entitled by the holders of the Series B-1 Preferred Shares and Series B-2 Preferred Shares under the Transaction Documents shall require the prior written consent of the Majority Series B-1 and B-2 Preferred Holders (d) any disproportionate or unfair change of rights, privileges and preference of the Series B-3 Preferred Shares entitled by the holders of the Series B-3 Preferred Shares under the Transaction Documents shall require the prior written consent of the Majority Series B-3 Preferred Holders; (e) any disproportionate or unfair change of rights, privileges and preference of the Series B-3+ Preferred Shares entitled by the holders of the Series B-3+ Preferred Shares under the Transaction Documents shall require the prior written consent of the Majority Series B-3+ Preferred Holders; (f) any disproportionate or unfair change in share reserve of rights, privileges and preference of the Series C Preferred Shares entitled by the holders of the Series C Preferred Shares under the ESOP (as defined in Transaction Documents shall require the Series B Share Purchase Agreement) or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any prior written consent of the Group CompaniesMajority Series C Preferred Holders; (g) any approval disproportionate or unfair change of or adjustments or modification to the terms of any transaction involving the interest of any directorrights, employee, officer, management member or shareholder of any privileges and preference of the Group Companies, including but not limited to Series D Preferred Shares entitled by the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder holders of the Group Companies;Series D Preferred Shares under the Transaction Documents shall require the prior written consent of the Majority Series D Preferred Holders; and (h) any action that results in disproportionate or unfair change of rights, privileges and preference of the payment or declaration Series E Preferred Shares entitled by the holders of a dividend or other distribution on the Series E Preferred Shares under the Transaction Documents shall require the prior written consent of the Majority Series E Preferred Holders. Notwithstanding anything to the contrary contained herein, any Ordinary Shares or Preferred Shares; (i) any merger, consolidation or amalgamation amendment of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any provision of the foregoing, Transaction Documents that affects any Investor disproportionately as compared to other holders of Preferred Shares holding the same class or other forms series of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any shares of the assets or rights Company shall additionally require the prior written consent of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant such Investor. Notwithstanding anything to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in officecontrary contained herein, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote shareholders voted in favor of such act listed in clause (a) to (h) above, but the approval of Majority Series Seed Preferred Holders, the holders of at least two-thirds (2/3) of the then outstanding Majority Series A Preferred Shares has not been obtainedHolders, then the Majority Series B-1 and B-2 Preferred Holders, the Majority Series B-3 Preferred Holders, the Majority Series B-3+ Preferred Holders, the Majority Series C Preferred Holders, the Majority Series D Preferred Holders, or the Majority Series E Preferred Holders, as applicable, have voted against any such act, such majority of holders of then outstanding Series A Preferred Shares, Shares who voted against such Special Resolution at a meeting act shall carry the number of the shareholders shall together carry 34% of the votes on such Special Resolution with equal to such votes being divided equally among held by all shareholders who voted in favor of such holders of the then outstanding Series A Preferred Sharesresolution plus one (1). 7.2. 9.3 In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, of the following acts of the any Group Companies, Company (whether in a single transaction or a series of related transactions, and whether directly or indirectly and whether indirectly, or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, ) shall require the prior written approval consent of a majority of the Board (which approval includes Directors, including the approval prior written consent of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned):the Requisite Investor Directors: (a) the extension of any appointment loan to any director, officer or change of the auditors, accounting policies, internal controls over financial reporting or the financial year employee of any Group Company; (b) any appointmenttransaction with any director, removal, replacement of the chief executive officer, the president, the chief financial officer (employee or financial vice president or financial controller), the chief technology officer and the chief operating officer shareholder of any Group Company, including approving any option plansCompany with a value of RMB1,000,000 or higher; (c) any approval or material amendment change to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure planCompanies (taken as a whole); (d) any equity investment or entering into any joint venture decision to proceed with any personan IPO, including engagement of the underwriters, intermediaries, the listing venue, timing, valuation and the stock exchange for the IPO; (e) the adoption, amendment or termination any change of the ESOP Principal Business as currently conducted or proposed to be conducted by the Group Companies, or any other equity incentive, purchase decision to cease to conduct or participation plan for carry on the benefit of any employees, officers, directors, contractors, advisors or consultants of any Principal Business of the Group Companies; (f) any incurrence, directly or indirectly, of any guarantee, mortgage, lien or other encumbrance on any securities or assets of any Group Company or its Affiliates, except for (i) trade accounts of any Group Company or its subsidiary incurred in the determination ordinary course of business consistent with past practice, (ii) the transactions included in the budget of the exercise price for any share options Group Companies, or other equity incentives; or(iii) a single or series of transactions that may incur liabilities in aggregate on the Group Companies (taken as a whole) not exceeding 5% of the total revenue of the Group Companies (taken as a whole) in the previous fiscal year; (g) any action by a settlement of any material litigation or arbitration of any Group Company (if applicable) to authorize, approve or enter into any agreement or obligation each with respect to any amount exceeding 5% of the actions listed abovetotal revenue of the Group Companies (taken as a whole) in the previous fiscal year; (h) approval of any transaction with value exceeding the annual budget by no less than 5% of the total revenue of the Group Companies (taken as a whole) in the previous fiscal year; and (i) the adoption of the consolidated annual budget of the Group Companies, or any deviation from or amendment to such budget which exceeds 15% of the total budget amount.

Appears in 1 contract

Sources: Shareholder Agreements (Yatsen Holding LTD)

Protective Provisions. 7.1. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstandingMemorandum and Articles and the BVI Business Companies ▇▇▇ ▇▇▇▇, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, Company shall require the prior written approval of the holders holder(s) of at least twoseventy-thirds five percent (2/375%) of the then outstanding Series A Preferred Shares, voting as Shares (on an as-converted basis); provided that such requirement shall terminate upon a separate classQualified Public Offering: (a) any material change to the business scope, or nature of the business of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group Company; (b) any liquidation, dissolution or winding up of any Group Company, any consummation of a Liquidation Event or effecting any other merger or consolidation; (c) any sale, transfer, license, pledge or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, or any issuance, distribution, purchase or redemption of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (ei) any amendment or change of Restated Articles or other charter documents of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares of the Company; (ii) any action to authorize, create or issue shares of any class or series of the Company having preferences superior to or on a parity with the Preferred Shares in any aspects including without limitation dividend rights, redemption rights and/or liquidation rights; (iii) any new issuance of any equity securities of the Company, excluding (i) any issuance of the Series A1 Shares under the Purchase Agreement, (ii) any issuance of Ordinary Shares upon conversion of the Preferred Shares, and (iii) the issuance of up to 66.58 Ordinary Shares (or options or warrants therefor) under employee equity incentive plans approved by the Board and the Series A Preferred Shareholders; (iv) any action of the Company to reclassify any outstanding shares into shares having preferences or priority as to dividends or assets senior to or on a parity with the preference of the Preferred Shares; (fv) any change in share reserve under increase or decrease of the ESOP authorized number of Ordinary Shares or Preferred Shares of the Company; (vi) any repurchase or redemption of any equity securities of the Company other than pursuant to (A) the redemption right of the holders of Preferred Shares as defined provided in the Series B Share Purchase AgreementMemorandum and Articles, or (B) or any other equity incentive, purchase or participation plan for contractual rights to repurchase Ordinary Shares from the benefit of any employees, officers, directors, contractors, advisors directors or consultants of any the Company upon termination of their employment or services or pursuant to a contractual right of first refusal held by the Group CompaniesCompany; (gvii) any approval of or adjustments or modification to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any amendment of the Group Companies, including but not limited to the making Memorandum and Articles of any loans Association or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder other charter documents of the Group CompaniesCompany (including any Major Subsidiary); (hviii) any action that results merger or consolidation of the Company (including any Subsidiary) with or into any other business entity in which the shareholders of the Company (including any Subsidiary) immediately after such merger or consolidation held shares representing less than a majority of the voting power of the outstanding share capital of the surviving business entity; (ix) the sale, lease, transfer or other disposition of all or substantially all of the assets of the Company (including any Subsidiary), except for intra-group transactions among the Company and any Subsidiaries; (x) any licensing or otherwise transfer of the patents, copyrights, trademarks or other intellectual property of the Company (including any Subsidiary) other than in the ordinary course of its business, except for intra-group transactions among the Company and any Subsidiaries; (xi) any increase or decrease of the authorized number of the board members of the Company; (xii) the liquidation, dissolution or winding up of the Company (including any Subsidiary); (xiii) the declaration or payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Shares; (i) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any Shares of the foregoing, or other forms of restructuring of any Group Company; (jxiv) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any increase of the assets or rights number of Ordinary Shares of the Company reserved under any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Companyemployee equity incentive plan; (kxv) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change increase in compensation of any employee of the Company (including any Group Company Subsidiary) with an annual salary of US$50,000 or more by more than US$200,000 twenty percent (20%) in a twelve (12) month period; (xvi) the extension by the Company of any loan or guarantee for indebtedness to any director, officer, employee or affiliate of the Company (including any Subsidiary), except for intra-group transactions among the Company and any Subsidiaries; (xvii) any incurrence of indebtedness in excess of US$300,000 in the aggregate to the Company (including any Subsidiary), or creation of any encumbrance whatsoever upon the assets, patents, copyrights, trademarks or other intellectual property of the Company (including any Subsidiary); (xviii) any purchase by the Company (including any Subsidiary) of real property with a value of US$300,000 or more, or any purchase of production facilities with a value of US$500,000 or more, individually or in the aggregate; (xix) any transaction or series of transactions that are not in the ordinary course of the Company’s business where the value involved exceeds US$300,000, individually or in the aggregate, during any twelve (12) month period; (xx) approval of the annual consolidated budget of the Company; or (nxxi) the appointment and removal of any appointment, removal, replacement key officer of the directors Company (including any Major Subsidiary), including the Chief Executive Officer and the Chief Financial Officer; (xxii) the appointment and/or reappointment of any Group Company; For the avoidance of doubt, if any auditors of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (bxxiii) any appointment, removal, replacement of transaction involving both the chief executive officer, the president, the chief financial officer Company (including any Subsidiary) and a shareholder or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any Company’s employees, officers, directors, contractors, advisors directors or consultants shareholders or any affiliate of a shareholder or any of its officers, directors or shareholders, except for intra-group transactions among the Group Companies; (f) the determination of the exercise price for Company and any share options or other equity incentivesSubsidiaries; or (gxxiv) any action by a Group items of capital expenditure outside the annual budget of the Company (if applicableincluding any Subsidiary) to authorizein excess of US$150,000 per month, approve individually or enter into any agreement or obligation with respect to any of in the actions listed aboveaggregate.

Appears in 1 contract

Sources: Series A1 Preferred Share Purchase Agreement (Le Gaga Holdings LTD)

Protective Provisions. 7.1. In addition to such other limitations as may be provided in the Restated Articles, for so So long as any Series A shares of Preferred Shares Stock are outstanding, the following acts Corporation shall not without first obtaining the approval (by vote or written consent, as provided by law) of the Group Companiesholders of a majority of the Preferred Stock, whether in voting together as a single class: (i) sell, convey, or otherwise dispose of all or substantially all of its property or business or merge into or consolidate with any other corporation (other than a wholly-owned subsidiary corporation) or effect any other transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the holders of at least two-thirds transactions in which more than fifty percent (2/350%) of the then outstanding Series A Preferred Shares, voting as a separate class: (a) any material change to the business scope, or nature power of the business Corporation is disposed of, provided -------- that this Section 6(a)(i) shall not apply to a merger effected exclusively for the purpose of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation changing the domicile of any existing business line of any Group Companythe Corporation; (bii) any liquidationauthorize or issue, dissolution or winding up of any Group Companyobligate itself to issue, any consummation of a Liquidation Event or effecting other equity security, including any other merger security convertible into or consolidationexercisable for any equity security having a preference over, or being on a parity with, the Preferred Stock with respect to voting, redemption, devidends or upon liquidation; (ciii) any sale, transfer, license, pledge or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, or any issuance, distributionredeem, purchase or redemption of any shares, otherwise acquire (or securities convertible pay into or carrying set funds aside for a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (esinking fund such purpose) any amendment share or shares of Restated Articles Preferred Stock or other charter documents Common Stock; provided, however, that this restriction shall not apply -------- ------- to the repurchase of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares and the Series A Preferred Shares; (f) any change in share reserve under the ESOP (as defined in the Series B Share Purchase Agreement) or any other equity incentive, purchase or participation plan for the benefit shares of any Common Stock from employees, officers, directors, contractorsconsultants or other persons performing services for the Company or any subsidiary pursuant to agreements under which the Company has the option to repurchase such shares at cost upon the occurrence of certain events, advisors or consultants such as the termination of any of the Group Companiesemployment; (giv) any approval amend the Corporation's Certificate of Incorporation or adjustments or modification to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Shares; (i) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any of the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month periodbylaws; or (nv) any appointment, removal, replacement change the authorized number of directors of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred SharesCorporation. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed above.

Appears in 1 contract

Sources: Series B Preferred Stock Purchase Agreement (Avantgo Inc)

Protective Provisions. 7.1. In addition Subject to such other limitations as the rights of series or classes of Preferred Stock which may be provided from time to time come into existence in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, accordance with the following acts of Protective Provisions, this Company shall not without first obtaining the Group Companiesapproval (by vote or written consent, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not as provided by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval law) of the holders of at least two-thirds (66 2/3) % of the then outstanding shares of Series A Preferred Shares, Stock voting as a separate class: (a) any material change to the business scopea. sell, convey, or nature otherwise dispose of the business all or substantially all of any Group Company, engagement in or investment in any new line its property or business or salemerge into or consolidate with any other company (other than a wholly-owned subsidiary company) or effect any other transaction or series of related transactions in which more than fifty percent (50%) of the voting power of the Company is disposed of, disposal or cessation provided that this Section 6(a) shall not apply to a merger effected exclusively for the purpose of any existing business line changing the domicile of any Group the Company; (b) any liquidation, dissolution b. amend or winding up modify the Restated Certificate of any Group Incorporation or Bylaws of the Company, any consummation of a Liquidation Event or effecting any other merger or consolidation; (c) any sale, transfer, license, pledge c. amend or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, or any issuance, distribution, purchase or redemption of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (e) any amendment of Restated Articles or other charter documents of any Group Company which alters or adversely affects change the rights, preferences, preferences or privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares and of the Series A Preferred SharesStock; (f) any change in share reserve under the ESOP (as defined in the Series B Share Purchase Agreement) d. authorize or issue, or obligate itself to issue, any other equity incentivesecurity including any other security convertible into or exercisable for any equity security, having a preference over, or being on a parity with, the Series A Preferred Stock with respect to voting dividends or upon liquidation; e. redeem, purchase or participation plan otherwise acquire (or pay into or set funds aside for a sinking fund for such purpose) any share or shares of Preferred Stock or Common Stock; provided, however, that this restriction shall not apply to the benefit repurchase of any shares of Common Stock from employees, officers, directors, contractorsconsultants or other persons performing services for the Company or any subsidiary pursuant to agreements under which the Company has the option to repurchase such shares at cost or at cost upon the occurrence of certain events, advisors such as the termination of employment; f. increase or consultants decrease the authorized Preferred Stock; g. reclassify or recapitalize the capital stock of the Company; h. effect the liquidation of the Company; or i. issue (directly or pursuant to the exercise of any option) or authorize or reserve for issuance to employees, consultants and directors as equity incentive compensation in excess of 2,500,000 shares of Common Stock, whether or not pursuant to a benefit plan, and taking into account all such shares that have been so issued, authorized or reserved as of the Group Companies; (g) any approval date of or adjustments or modification to filing of this Restated Certificate of Incorporation. In addition, the terms consent of any transaction involving the interest of any director, employee, officer, management member or shareholder of any 66 2/3% of the Group CompaniesSeries A Preferred Stock, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security shall be required for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Shares; (i) any mergeradversely effects the rights, consolidation preferences or amalgamation privileges of any Group Company with the Series A Preferred Stock in a manner different from that of other classes of Preferred Stock that might be created, (ii) creates or is likely to create a conflict of interest between the Series A Preferred Stock and any other entity class of Preferred Stock that might be created, or entities (iii) creates a class or any spin-off, sub-division, series of stock or any other transaction of a similar nature or having a similar economic effect as any of the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any securities convertible into equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of Company having a preference over the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred SharesStock. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed above.

Appears in 1 contract

Sources: Preferred Stock Purchase Warrant (Bayhill Therapeutics, Inc.)

Protective Provisions. 7.1. In addition to such other limitations as may be provided in the Restated Articles, for For so long as any the Purchaser beneficially owns a number of Series A Preferred Shares are outstanding, the following acts and/or Ordinary Shares issued upon conversion of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the holders of Series A Shares equal to at least two-thirds fifty percent (2/350%) of the then outstanding Series A Preferred SharesShares issued at the Closing (in each case, voting as a separate class:appropriately adjusted for stock splits, reverse stock splits, stock dividends, stock consolidations, recapitalizations and the like), in addition to any other vote or consent of the Company’s shareholders required by law or by the Memorandum and Articles, the Company shall not, and shall cause each of its controlled Subsidiaries and Beijing ▇▇▇▇▇▇ ▇▇▇ Information Technology Co., Ltd. not to, as applicable, without the affirmative vote or written consent of the Purchaser who is the record holder of the Series A Shares at such time (which consent, except as expressly provided below, may be given or withheld, or made subject to such conditions as are determined by the Purchaser, in its sole discretion): (a) amend, alter or repeal the Memorandum and Articles or any material change to provision thereof, including the business scopeCertificate of Designations or any other instrument establishing or designating the Series A Shares, or nature otherwise amend the terms of the business of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group CompanySeries A Shares; (b) any liquidationauthorize, dissolution designate or winding up of any Group Company, any consummation of a Liquidation Event or effecting issue any other merger security convertible into or consolidationexercisable for any equity security having rights, privileges or preferences senior to or on parity with the Series A Shares; (c) declare or pay any saledividend on, transferor make any distributions relating to, licenseany Junior Shares (including pursuant to clause (d) of this Section 7.1) or redeem, pledge purchase or encumbering all acquire for value any (x) Junior Shares, or all substantial technology (y) any options, warrants or intellectual propertyother rights to acquire such Junior Shares, other than non-exclusive licenses granted purchases, redemptions or other acquisitions of such Junior Shares in connection with any employment contract, benefit plan or other similar arrangement with or for the ordinary course benefit of businessemployees, officers, directors or consultants and other than as permitted under Section 5(e) of the Investment Agreement; (d) any increasedistribute (by way of dividend, decrease share distribution, exchange, redemption, recapitalization or cancellation similar transaction) securities of any authorized or outstanding shares entity holding a significant portion of the assets and business of any Group Company, or any issuance, distribution, purchase or redemption member of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the BoardGroup, including each Series A Director then in officeby way of spin-off, if any)split-off or other distribution transaction; (e) any amendment of Restated Articles or other charter documents of any Group Company which alters or adversely affects the rights, preferences, privileges or powers ofenter into, or permit any Subsidiary to enter into, any agreement, or any modification or amendment to an existing agreement, which, in the restrictions provided for absence of a default under such agreement, would by its terms prevent the benefit of, the Series B Preferred Shares and Company from fully performing its obligations with respect to the Series A Preferred Shares; (f) incur any change in share reserve material indebtedness, except as permitted under the ESOP (terms of any credit facility then in place, renewing existing credit facilities in similar terms, or as defined provided in the Series B Share Purchase Agreement) or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies;Group’s annual business plan;or (g) any approval of agree or adjustments or modification undertake to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Shares; (i) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as do any of the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed above.

Appears in 1 contract

Sources: Investor's Rights Agreement (AutoNavi Holdings LTD)

Protective Provisions. 7.1. In addition to such other limitations as may be provided in the Restated Memorandum and Articles, for so long the Founders, the Investors and the Ordinary Shareholders in their capacity as shareholders (and not directors) and the Company solely in respect of other members of the Company Group and not itself agree to do all such things and to take all such actions (including by voting equity securities of the Company held by them and, in respect of the Founders and Ordinary Shareholders only, by procuring the votes of directors designated by them) to procure that neither the Company nor any Series A member of the Company Group shall undertake any of the actions set out in (i) to (xxii) below without the written consent of all Preferred Directors (except that in the event any holder or holders of Preferred Shares are outstandingelect not to designate a Preferred Director such holder(s) have the right to designate, then the consent of any Board Observer designated pursuant to Section 11.8(i), if any, shall be required). To the extent permitted by applicable Law, the following acts Company agrees as regards itself (and not other members of the Group CompaniesCompany Group) not to take any of the actions set out in (i) to (xxii) below without the written consent of all Preferred Directors (except that in the event any holder or holders of Preferred Shares elect not to designate a Preferred Director such holder(s) have the right to designate, whether then the consent of any Board Observer designated pursuant to Section 11.8(i), if any, shall be required) (provided, however, that none of the foregoing provisions shall be deemed to require the approval of the Preferred Director or the Board Observer, as the case may be, with respect to any action permitted by the Annual Capital Budget or any deminimus action which is reasonably required to implement any action for which approval is not required or has already been granted in accordance with this Section 12.9): (i) Authorize or issue any additional, or additional series of, Preferred Shares or any other new class or series of equity securities or any securities convertible into equity securities of the Company. (ii) Purchase, repurchase or redeem (a) Ordinary Shares, (b) securities or rights of any kind convertible into or exercisable or exchangeable for Ordinary Shares or (c) other securities of the Company (except (i) in the case of a termination of an employee, at which the Company may repurchase or redeem such Ordinary Shares at cost and pursuant to any agreement under which such Ordinary Shares were issued, or (ii) for redemption of the Preferred Shares in accordance with the Memorandum and Articles). (iii) Enter into, or enter any binding agreement to enter into, any transaction which would, upon consummation, constitute a Change-of-Control Event. (iv) Sell, mortgage, pledge, transfer, lease or otherwise dispose of 50% or more of its consolidated assets (as shown on the most recent financial statements of any member of the Company Group) in any single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the holders of at least two-thirds transactions (2/3) of the then outstanding Series A Preferred Shares, voting as a separate class: (a) any material change to the business scope, or nature of the business of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group Company; (b) any liquidation, dissolution or winding up of any Group Company, any consummation of a Liquidation Event or effecting any other merger or consolidation; (c) any sale, transfer, license, pledge or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted the sale of inventory in the ordinary course of business;), or liquidate, dissolve, recapitalize or reorganize in any form of transaction. (dv) Effect any increasereclassification, decrease combination or cancellation reverse stock split of the Ordinary Shares. (vi) Amend any article or provision of the Memorandum and Articles. (vii) Establish any Subsidiary or make any investment in any equity or equity-related securities of any authorized Person (other than an entity controlled by the Company), or outstanding shares enter into any joint venture or partnership other than a strategic alliance not involving any equity or equity-related investment. (viii) Incur any debt or any other financial obligations exceeding US$10,000,000; provided, however, no approval shall be required in order for the Company and its subsidiaries to maintain its current level of indebtedness. (ix) Make any Group capital expenditure or other purchase of tangible or intangible assets in any fiscal year that in the aggregate (on a consolidated basis) exceeds US$1,000,000. (x) Acquire, through purchase, lease or rental any automobile or motor vehicle valued or having a purchase price in excess of US$30,000 (other than vehicles used in the conduct of the Company’s business with the purchase price for all such vehicles not to exceed US$300,000 in the aggregate), or any issuancereal estate other than the office space occupied by the Company and its Subsidiaries as of the date of this Agreement. (xi) Make any decision with respect to the prosecution or settlement of legal actions, distribution, purchase where the aggregate amount of all claims so prosecuted or redemption settled would exceed US$1,000,000 within any fiscal year. (xii) Change the domicile of any sharesmember of the Company Group. (xiii) Change the external auditor to a Person which is not one of the Big-4 accounting firms or any material changes to the accounting methods or policies of any member of the Company Group. (xiv) Enter into any transaction or agreement with a Related Party which is outside of the ordinary course of business, or securities convertible into material or carrying a right of subscription in respect not on an arm’s length basis. (xv) Determine the timing and valuation of any shares or any warrant or any grant or issuance IPO of options (other than pursuant to an equity incentive plan approved by the Boardsecurities of the Company that is not a Qualified IPO, including each Series A Director then in office, if any);the securities exchange on which such securities shall be listed and the lead book-runner for such listing. (exvi) any amendment of Restated Articles or other charter documents of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares and the Series A Preferred Shares; (f) Make any change in share reserve under the ESOP (as defined Company’s name or any material change in the Series B Share Purchase Agreement) or any other equity incentive, purchase or participation plan for the benefit primary business of any employeesmember of the Company Group, officers, directors, contractors, advisors or consultants the addition of any new business to any member of the Group Companies;Company Group, the termination of any material existing business of any member of the Company Group. (gxvii) Make any approval of material amendment or adjustments or modification change to the employment and / or employment terms of any transaction involving Key Employee. (xviii) Increase the interest authorized number of directors of any directormember of the Company Group. (xix) License or transfer any of patents, employeecopyrights, officer, management member trademarks or shareholder other intellectual property of any member of the Company Group Companies, including but not limited which are material to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder operations of the Company Group Companies;other than in the ordinary course of its business. (hxx) File for winding up, bankruptcy, dissolution or liquidation with respect to any action member of the Company Group (including any Liquidation Event, as such term is defined herein). (xxi) Approve or adopt any annual capital expenditure budget (the “Annual Capital Budget”) and any amendment to a previously approved or adopted Annual Capital Budget; provided, that results approved or adopted Annual Capital Budget must be approved in accordance with this clause (xxi) prior to the commencement of business operations in the payment or declaration relevant fiscal year and provided further that such first Annual Capital Budget shall include a budget item for up to US$75 million for future acquisitions of a dividend or other distribution on any Ordinary Shares or Preferred Shares;hydroelectric assets in the PRC. (ixxii) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as Agree to undertake to do any of the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed above.

Appears in 1 contract

Sources: Shareholder Agreements (China Hydroelectric Corp)

Protective Provisions. 7.1. In addition to such other limitations as may be provided in the Restated Articles, for For so long as any shares of Series A Preferred Shares are Stock shall be outstanding, the following acts of the Group CompaniesCorporation shall not, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not indirectly, by amendment, merger, consolidation, scheme of arrangement, amalgamation, consolidation or otherwise, shall require without (in addition to any other vote required by the Certificate of Incorporation or by applicable law) the prior written approval vote or consent of the holders of at least two-thirds (2/3) a majority of the then outstanding shares of Series A Preferred SharesStock, voting or consenting separately as a separate single class: (a) , and any material change such act or transaction entered into without such vote or consent shall, to the business scopefullest extent permitted by applicable law, be null and void ab initio, and of no force or nature of the business of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group Company; (b) any liquidation, dissolution or winding up of any Group Company, any consummation of a Liquidation Event or effecting any other merger or consolidation; (c) any sale, transfer, license, pledge or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, or any issuance, distribution, purchase or redemption of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (e) any amendment of Restated Articles or other charter documents of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares and the Series A Preferred Shares; (f) any change in share reserve under the ESOP (as defined in the Series B Share Purchase Agreement) or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (g) any approval of or adjustments or modification to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Shares;effect: (i) Amend, alter or repeal any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any provision of the foregoingCertificate of Incorporation or this Certificate of Designation if such amendment, alteration or other forms repeal would alter or change the powers, preferences or special rights of restructuring the shares of any Group CompanySeries A Preferred Stock so as to affect them adversely; (jii) Create, authorize the creation of or issue any creation, authorization or issuance series of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group CompanyPreferred Stock; (kiii) Reclassify any initial public offering class or series of capital stock into any equity securities series of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offeringPreferred Stock; (liv) Purchase or redeem, or permit any acquisition subsidiary of the Corporation to purchase or redeem, any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year shares of any of the Group CompaniesSeries A Dividend Junior Stock, Series A Liquidation Junior Stock, Series A Qualifying Merger Junior Stock or Series A Qualifying Sale Junior Stock, other than pursuant to repurchases of shares of such capital stock from former directors, officers, employees, consultants or other individuals performing services for the annual budget Corporation or any subsidiary of the Corporation in connection with the cessation of employment or service and business plan approved by for a purchase price per share of such capital stock not exceeding the Board, including the affirmative vote of each Series A Director then in office, if anyoriginal purchase price thereof; (mv) Declare or pay any settlement dividend on any Series A Dividend Junior Stock; (vi) Incur or alteration issue, or permit any subsidiary of the Corporation to incur or issue, any indebtedness for borrowed money (including loans, debt securities and obligations (whether or not contingent) under guarantees of indebtedness of any employment agreementother Person), salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (extent that such indebtedness would cause the Company to be insolvent, as defined determined by the Company in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month periodits reasonable discretion; or (nvii) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamationEnter into, or otherwisepermit the Corporation’s subsidiaries to enter into, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in officeany agreement, if any, whose approval shall not be unreasonably withheld, delayed arrangement or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan understanding providing for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed abovedescribed in the aforesaid clauses (i) - (vi).

Appears in 1 contract

Sources: Business Combination Agreement (Arena Group Holdings, Inc.)

Protective Provisions. 7.1. In addition to such other limitations as may be provided in the Restated Articles, for For so long as any Series A Preferred Shares are outstandingthe Note remains outstanding in full and is not then expired, terminated or converted, the following acts of the Group CompaniesCompany shall not, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not indirectly, by amendmentamendment to the Company’s organizational documents, merger, consolidationconversion, scheme of arrangement, amalgamation, consolidation or otherwise, shall require take any of the following actions without the prior written approval consent of Investor; provided, that in the case of (b) below, such Investor consent shall not be required if such action has been approved by sufficient shareholders to approve such action under the shareholder rights agreements and/or certificate of incorporation of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares, voting as a separate classCompany: (a) any material change to liquidate, dissolve or wind-up the business scopeand affairs of the Company, effect any amalgamation or consolidation or any other voluntary termination of operations, general assignment for the benefit of creditors or Change of Control, or nature consent to any of the business foregoing (any of any Group Companythe foregoing, engagement in or investment in any new line or business or salea “Dissolution Event”), disposal or cessation of any existing business line of any Group Companyprovided that the above approval is required only if the proceeds that will be payable to Investor will equal less than the aggregate amount payable under the Note at such time (including all accrued interest and outstanding principal); (b) any liquidation, dissolution alter or winding up amend the authorized or issued capital stock of any Group Company, any consummation of a Liquidation Event or effecting any other merger or consolidationthe Company (“Capital Stock”); (c) (i) purchase or redeem (or permit any salesubsidiary to purchase or redeem) any shares of Capital Stock of the Company or (ii) pay or declare any dividend or make any distribution on any shares of Preferred Stock of the Company; (d) change the principal business of the Company, transferenter new lines of business, or exit the current line of business materially; (e) otherwise enter into or be a party to any transaction with any director, officer, or employee of the Company, except for transactions made in the ordinary course of business and pursuant to reasonable requirements of the Company’s business and upon fair and reasonable terms; (f) unless subject to clause (a) above, sell, assign, license, pledge pledge, or encumbering all encumber, or all substantial permit any subsidiary to sell, assign, license, pledge, or encumber: (i) material technology or intellectual property, other than non-exclusive licenses granted in the ordinary course of business; ; or (dii) any increase, decrease or cancellation other material assets of any authorized or outstanding shares of any Group the Company, or any issuance, distribution, purchase or redemption of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other at less than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (e) any amendment of Restated Articles or other charter documents of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares and the Series A Preferred Shares; (f) any change in share reserve under the ESOP (as defined in the Series B Share Purchase Agreement) or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companiesfair market value; (g) unless subject to clause (a) above, any approval transaction outside the ordinary course of business (as determined by Company’s board of directors (the “Board”)), including: (i) any loans, investments or adjustments guarantees other than credit to customers; (ii) establishing or modification acquiring any new business undertaking; and (iii) any partnership or joint venture (other than joint business arrangements with arm’s length third parties in the ordinary course of business); (h) enter into any corporate strategic relationship involving the payment, contribution, or assignment by the Company (and/or its subsidiaries) or to the terms Company (and/or its subsidiaries) of money or assets, not approved by the Board in the Company’s business plan from time to time, greater than $2,500,000; (i) either create, or authorize the creation of, or issue, or authorize the issuance of any transaction involving debt security or create any lien or security interest (except for purchase money liens or statutory liens of landlords, mechanics, materialmen, workmen, warehousemen and other similar persons arising or incurred in the interest ordinary course of any director, employee, officer, management member business) or shareholder incur other indebtedness for borrowed money if the aggregate indebtedness of any of the Group Companiessuch action would exceed $250,000, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Shares; (i) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any of the foregoing, or other forms of restructuring of any Group Companyobligations and contingent obligations under guarantees; (j) create, authorize the creation of, or issue or obligate itself to issue any creation, authorization convertible debt or issuance of similar securities (including any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company;SAFEs); or (k) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect arrangement to effect any of the actions listed aboveforegoing.

Appears in 1 contract

Sources: Side Letter Rights Agreement (Greenfield Robotics Corp)

Protective Provisions. 7.1. In addition to such other limitations as may be provided in The Company shall not, without the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction affirmative vote or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval consent of the holders of at least twomore than seventy-thirds five percent (2/375%) of all of the then outstanding shares of Series A Preferred SharesStock and if there are no Series A Preferred Stock outstanding, seventy-five percent (75%) of the Common Stock (for purposes of making any determination or calculation pursuant to this Section 3.6, but for such purposes only, as of any date of determination or calculation, all of the Capital Stock of the Company that is then convertible or exercisable into or exchangeable for Common Stock shall be deemed to have been so converted, exercised or exchanged in full as of such date of determination or calculation), voting separately as a separate class: , (i) declare, pay dividends or make any other distribution to holders of shares of Capital Stock or redeem or repurchase or otherwise acquire any shares of Capital Stock, other than as required by law or by agreements in existence on the date hereof with employees or consultants of the Company requiring or permitting the redemption or repurchase of shares of Capital Stock; (ii) amend or repeal any provision of, or add any provision to, the Company’s articles of incorporation, bylaws, or any certificate of designations or file any certificate of designations, preferences, limitations and relative rights of any series of preferred stock other than as contemplated by the Purchase Agreement; (iii) increase the number of shares to be reserved for issuance under any compensation plan of the Company; (iv) make any loan or enter into any agreements, arrangements or other continuing transactions between (a) the Company or any material change to subsidiary on the business scopeone hand, or nature of the business of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group Company; and (b) any liquidation, dissolution or winding up of any Group Companyon the other hand, any consummation officer, employee, consultant or director of a Liquidation Event or effecting any other merger or consolidation; (c) any sale, transfer, license, pledge or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, or any issuance, distribution, purchase or redemption of any sharesits subsidiaries, or securities convertible into or carrying a right any person owning any capital stock of subscription in respect of any shares the Company or any warrant subsidiary or any grant member of the immediate family of such officer, employee, consultant, director or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (e) stockholder or any amendment of Restated Articles corporation or other charter documents of any Group Company which alters entity controlled by such officer, employee, consultant, director or adversely affects the rights, preferences, privileges or powers ofstockholder, or a member of the restrictions provided immediate family of such officer, employee, consultant, director or stockholder; (v) voluntarily file for bankruptcy, liquidate the benefit of, the Series B Preferred Shares and the Series A Preferred Shares; (f) any change in share reserve under the ESOP (as defined in the Series B Share Purchase Agreement) Company’s assets or any other equity incentive, purchase or participation plan make an assignment for the benefit of any employeesthe Company’s creditors; (vi) incur, officers, directors, contractors, advisors assume or consultants of any of the Group Companies; (g) any approval of or adjustments or modification to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with guarantee any indebtedness for borrowed money; (vii) issue or liabilities of purchase any director, employee, officer, management member equity or shareholder of the Group Companies; debt securities; (hviii) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Shares; (i) enter into any merger, reorganization, consolidation or amalgamation sale of any Group substantially all of the assets of the Company with any another corporation or other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any acquisition of the foregoing, Company; (ix) substantially alter or other forms of restructuring of change the Company’s business; (x) create any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any subsidiary of the assets Company; (x) alter or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate change in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination way the compensation of the listing venue, timing, valuation Company’s senior management; and other terms (xi) increase or decrease the size of the initial public offering; (l) any acquisition Company’s Board of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, Directors other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed abovethis Agreement.

Appears in 1 contract

Sources: Stockholders Agreement (Nascent Wine Company, Inc.)

Protective Provisions. 7.1. In addition So long as Purchaser (or any of its Permitted Transferees) continues to such other limitations as may be provided hold any interest in the Restated Articles, for so long as any Series A Preferred Shares are outstandingNote, the following acts Board (or to the extent applicable, any committee thereof) shall not approve, and neither the Company nor any Subsidiary of the Group CompaniesCompany shall take, whether in a single transaction or series any of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the actions set forth below unless the Company has received the prior written approval consent of the holders of at least two-thirds Purchaser (2/3) of the then outstanding Series A Preferred Shares, voting as a separate class:or such Permitted Transferee): (a1) any material change to in the business scope, or nature of the Business of the Company or its Subsidiaries; (2) any (A) acquisition of (x) any other Person or (y) business of any Group Companyother Person (whether by purchase of equity interests or assets, engagement or by merger or otherwise), or (B) entry into any material lease for additional teaching space that has annual rental obligations in excess of $1,000,000 per year (which consent may not be unreasonably withheld, conditioned or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group Companydelayed); (b3) any liquidationentry into, dissolution or winding up of any Group Companymodification of, any consummation agreement or transaction with any Unit Holder or any of a Liquidation Event its Affiliates (other than with respect to any capital raise permitted or effecting contemplated under the Operating Agreement, any customary agreements with Service Members relating to employment or equity-based compensation and any other merger or consolidation; (c) any sale, transfer, license, pledge or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted transaction arising in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, or any issuance, distribution, purchase or redemption of any shares, or securities convertible business that is entered into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to on an equity incentive plan approved by the Board, including each Series A Director then in office, if anyarm’s-length basis); (e4) any amendment of Restated Articles issuance or other charter documents sale of any Group Company which alters equity interests or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares and the Series A Preferred Shares; (f) any change in share reserve under the ESOP (as defined Convertible Securities in the Series B Share Purchase Agreement) or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (g) any approval of or adjustments or modification to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Shares; (i) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any of the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 its Subsidiaries to (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (kA) any initial public offering of Competitor or (B) any Person that does not specifically agree in writing to be subject to, and to Transfer its equity securities of any Group Company; determination interests to Nord or a third party (as applicable) as and when required by, Sections 7.4, 7.5(a) and 7.5(c) of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Operating Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month period; or (n5) any appointmentredemption, removal, replacement repurchase or re-acquisition of any equity interests or Convertible Securities in the Company or any of its Subsidiaries (other than repurchases of Units from Service Members pursuant to Sections 7.8 or 7.9 of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated ArticlesOperating Agreement), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed above.

Appears in 1 contract

Sources: Transaction Agreement (Nord Anglia Education, Inc.)

Protective Provisions. 7.1. In addition to such other limitations as may be provided in Except for the Restated Articlesdesignation and issuance of the Company’s Series B, for which is being designated contemporaneously with the Series A, so long as any shares of Series A Preferred Shares are outstanding, the following acts of Company shall not without first obtaining the Group Companiesapproval (by vote or written consent, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not as provided by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval law) of the holders of at least twoseventy-thirds five percent (2/375%) of the then outstanding shares of Series A Preferred SharesA, voting as a separate class: (a) in any material change manner authorize, issue or create (by reclassification or otherwise) any new class or series of shares having rights, preferences or privileges equal or senior to the business scope, or nature of the business of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group CompanySeries A; (b) any liquidationadversely alter or change the rights, dissolution preferences, designations or winding up privileges of any Group Company, any consummation of a Liquidation Event or effecting any other merger or consolidationthe Series A; (c) any sale, transfer, license, pledge amend the Company’s Articles of Incorporation or encumbering all or all substantial technology or intellectual property, other than nonBy-exclusive licenses granted laws in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, or any issuance, distribution, purchase or redemption of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (e) any amendment of Restated Articles or other charter documents of any Group Company which alters or manner that adversely affects the rights, preferences, designations or privileges or powers of, or of the restrictions provided for the benefit of, holders of the Series B Preferred Shares and the Series A Preferred SharesA; (fd) any change in share reserve under increase or decrease the ESOP authorized number of shares of preferred stock of the Company or otherwise reclassify the Company's outstanding securities; (as defined in the Series B Share Purchase Agreemente) or any other equity incentiveredeem, purchase or participation plan otherwise acquire (or pay into or set funds aside for a sinking fund for such purpose) any share or shares of preferred stock or Common Stock; provided, however, that this restriction shall not apply to the benefit de minimus repurchases of any shares of Common Stock from employees, officers, directors, contractorsconsultants or other persons performing services for the Company or any subsidiary pursuant to agreements under which the Company has the option to repurchase such shares at cost upon the occurrence of certain events, advisors such as the termination of employment, or consultants through the exercise of any right of the Group Companies; (g) first refusal; and provided further that this restriction shall not apply to any approval of or adjustments or modification to the terms of any transaction involving the interest of any directorconversion, employee, officer, management member or shareholder of any of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a dividend redemption or other distribution on any Ordinary Shares or Preferred Shares; (i) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any of the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of shares of Series A pursuant to this Certificate of Designations or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than Series B pursuant to the annual budget Certificate of Designations, Preferences and business plan approved by the Board, including the affirmative vote Rights of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation Convertible Preferred Stock of any employee of any Group Company by more than US$200,000 in a twelve (12) month periodthe Company; or (nf) any appointmentvoluntarily file for bankruptcy, removal, replacement of liquidate the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction ’s assets or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan make an assignment for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed aboveCompany’s creditors.

Appears in 1 contract

Sources: Series a Convertible Preferred Stock Purchase Agreement (Victory Divide Mining CO)

Protective Provisions. 7.1. In Except where the vote or written consent of the holders of a greater number of shares of capital stock of the Company is required by law or this Certificate, and in addition to such any other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstandingvote required by law or this Certificate, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether Company shall not either directly or indirectly and whether indirectly, by amendment of this Certificate, filing of a certificate of designation of preferences or not by amendmentrights, merger, consolidation, scheme reorganization, other transaction or series of arrangement, amalgamation, transactions or otherwise), shall require without first obtaining the prior approval (by vote or written approval of the holders of at least two-thirds (2/3consent, as provided by law) of the then outstanding Series A Preferred Shares, voting as a separate classRequisite Holders: (aA) amend, waive, alter or repeal any material change to provision of this Certificate or the business scope, or nature of the business of any Group Company, engagement in or investment 's Bylaws that would in any new line manner adversely affect, alter, change or business or sale, disposal or cessation of any existing business line of any Group Company; (b) any liquidation, dissolution or winding up of any Group Company, any consummation of a Liquidation Event or effecting any other merger or consolidation; (c) any sale, transfer, license, pledge or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, or any issuance, distribution, purchase or redemption of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (e) any amendment of Restated Articles or other charter documents of any Group Company which alters or adversely affects otherwise impair the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares and of the Series A Preferred SharesPreferred; (fB) authorize, effectuate or consummate a Liquidation Event; (C) sell or otherwise dispose of a material portion of its assets, properties or rights by the Company or its subsidiaries taken as a whole; (D) increase or decrease (other than by redemption or conversion) the total number of authorized shares of Series A Preferred; (E) authorize, create or issue, or obligate itself to issue, any change in share reserve under the ESOP (as defined in the Series B Share Purchase Agreement) class or series of shares of capital stock or any other equity incentivesecurity (including, without limitation, any other security convertible into or exercisable or exchangeable for any such equity security) having any rights, preferences or privileges senior to or on a parity with, any series of Series A Preferred); (F) redeem, purchase or participation plan otherwise acquire (or pay into or set aside for a sinking fund for such purpose) any securities or right to acquire securities of the benefit Company; provided, however, that this restriction shall not apply to the repurchase at cost of any shares of Common Stock from employees, officers, directors, contractors, advisors consultants or consultants other persons performing services for the Company or any subsidiary upon cessation of any services or pursuant to a right of first refusal right of first offer or similar repurchase rights in favor of the Group CompaniesCompany; (gG) any approval change the authorized number of or adjustments or modification to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any directors of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group CompaniesCompany; (hH) cause the Company to incur any action that results indebtedness for borrowed money in excess of $500,000 in the payment aggregate (excluding equipment leases, lines of credit or declaration of a other debt financing approved by the Board); (I) declare or pay any dividend or distribution, or make or set aside any other distribution on any Ordinary Shares or Preferred Sharesequity securities of the Company, other than the Series A Cumulative Dividends in respect of the Series A Preferred; (iJ) adopt or amend any mergerIncentive Plan, consolidation including to increase the number of shares of Common Stock or amalgamation options therefor reserved for issuance or grant thereunder in excess of an aggregate of 8,671,779 shares of Common Stock (subject to equitable adjustment for any Group Company with any other entity or entities or any spin-offstock dividends, sub-divisioncombinations, or any other transaction of a similar nature or having a similar economic effect as any of subdivisions, splits, recapitalizations and the foregoing, or other forms of restructuring of any Group Companylike after the Filing Date) under all Incentive Plans; (jK) assign ownership (in whole or part) of, or grants an exclusive license to, grants any creationcovenant not to sue, authorization or issuance otherwise grants any option for an assignment of, or exclusive license to or covenant not to sue in respect of any debenture constituting a pledgeintellectual property owned or used by the Company other than to its wholly-owned subsidiary, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company▇▇▇▇▇▇ CourtB.V; (kL) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offeringappoint a new Chief Executive Officer; (lM) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any change the principal business of the Group CompaniesCompany, other than pursuant to enter into new lines of business or exit the annual budget and business plan approved by line ofbusiness in which the Board, including Company is engaged as of the affirmative vote of each Series A Director then in office, if anyFiling Date; (mN) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment adopt or change of the Company's accounting practices or appoint or change the Company's auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed above.

Appears in 1 contract

Sources: Purchase Agreement

Protective Provisions. 7.1. In addition to such other limitations as may be voting rights provided in the Restated Articlesby law, for so long as any Series A shares of Preferred Shares are outstandingStock shall be outstanding (as adjusted for all stock splits, stock dividends, consolidations, recapitalizations and reorganizations), the following acts of Corporation shall not, without the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval consent of the holders of at least two-thirds (2/3) a majority of the then outstanding Series A shares of Preferred SharesStock, voting given in person or by proxy, either in writing or by vote at a meeting called for that purpose at which the holders of the Preferred Stock shall vote together as a separate classclass and to the exclusion of all other classes of capital stock of the Corporation: (ai) declare or pay any material change to the business scope, or nature dividends on any capital stock of the business of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group CompanyCorporation; (bii) redeem or repurchase capital stock of the Corporation except in connection with the repurchase of shares of Common Stock issued to or held by employees, consultants, officers and directors upon termination of their employment or services pursuant to agreements providing for the right of said repurchase, which agreements were authorized by the Board of Directors; (iii) take any liquidation, dissolution or winding up of any Group Company, any consummation of action which would result in a Liquidation Event or effecting any other merger or consolidationa Deemed Liquidation Event; (civ) any sale, transfer, license, pledge increase or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted in decrease the ordinary course total number of businessauthorized members of the Board of Directors; (dv) any increaseauthorize, decrease create or cancellation issue (whether by merger, consolidation, reclassification, amendment of any authorized this Amended and Restated Certificate of Incorporation, sale or outstanding otherwise) shares of any Group Company, class or any issuance, distribution, purchase or redemption series of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (e) any amendment of Restated Articles or other charter documents of any Group Company which alters or adversely affects the stock not authorized herein having rights, preferences, preferences or privileges superior to or powers of, or the restrictions provided for the benefit of, on parity with the Series B B-2 Preferred Shares and the Series A Preferred Shares; (f) any change in share reserve under the ESOP (as defined in the Series B Share Purchase Agreement) or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (g) any approval of or adjustments or modification to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Shares; (i) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any of the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month periodStock; or (nvi) take any appointment, removal, replacement action to amend or waive any provision of the directors this Amended and Restated Certificate of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting Incorporation or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed above’s Bylaws.

Appears in 1 contract

Sources: License Agreement (GTX Inc /De/)

Protective Provisions. 7.1. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts The consent of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the holders of at least two-thirds majority (2/351%) of the then outstanding Series A Preferred Shares, voting as a separate class: (a) any material change to the business scope, or nature of the business of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group Company; (b) any liquidation, dissolution or winding up of any Group Company, any consummation of a Liquidation Event or effecting any other merger or consolidation; (c) any sale, transfer, license, pledge or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, or any issuance, distribution, purchase or redemption of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (e) any amendment of Restated Articles or other charter documents of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares and Stock shall be required for any action which (i) alters or changes the Series A Preferred Shares; (f) any change in share reserve under the ESOP (as defined in rights, preferences or privileges of the Series B Share Purchase AgreementPreferred Stock, (ii) increases or decreases the authorized number of shares of Series B Preferred, (iii) creates (by reclassification or otherwise) a new series of preferred stock, (iv) results in the issuance of any equity security of the Company, other than equity securities issuable upon the exercise of options or warrants outstanding as of the date of this Certificate of Determination and other than up to 500,000 additional options that may be issued under the Company's stock option and incentive plans (and any equity securities issuable upon the exercise of such additional options), (v) results in any merger, sale of shares of capital stock having voting power with respect to thirty-five percent (35%) or more of the Company's outstanding capital stock, or any transaction in which all or substantially all of the assets of the Corporation are sold, (vi) amends or waives any provision of the Corporation's Restated Articles of Incorporation or Bylaws that affect the rights or privileges of the Series B Preferred shareholders or which create a new investor level with priority over the Series B Preferred shareholders or (vii) results in the Company's incurrence of any additional indebtedness for borrowed money. The Company shall not, by amendment of its Restated Articles of Incorporation or through any other equity incentivevoluntary action, purchase avoid or participation plan for seek to avoid the benefit of any employees, officers, directors, contractors, advisors observance or consultants performance of any of the Group Companies; (g) any approval of or adjustments or modification to the terms of any transaction involving the interest this Certificate of any directorDetermination, employee, officer, management member or shareholder of any of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or shall at all times in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results good faith assist in the payment or declaration carrying out of a dividend or other distribution on any Ordinary Shares or Preferred Shares; (i) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any of the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) such terms and in the aggregate taking of all such action as may be necessary or appropriate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination of order to protect the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval rights of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly herein and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of attempt to do indirectly what it cannot do directly under the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed aboveterms hereof.

Appears in 1 contract

Sources: Series B Preferred Stock Purchase Agreement (3dfx Interactive Inc)

Protective Provisions. 7.1. In addition to such other limitations as may be provided in the Restated Articles, for so So long as any Series A the Lead Investor and its Affiliates collectively beneficially own at least twenty percent (20%) of the Conversion Shares underlying the Preferred Shares are outstandingissued pursuant to the Securities Purchase Agreement (assuming the full conversion of such Preferred Shares, irrespective of any ownership limitations contained therein), the following acts of the Group CompaniesCompany shall not, whether in a single transaction or series of related transactions, whether either directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangementrecapitalization, amalgamationreclassification, or otherwise, shall require the prior written approval do any of the holders following without (in addition to any other vote required by law or the Company’s Articles of at least two-thirds (2/3Incorporation) the written consent of the then outstanding Series A Preferred SharesLead Investor, voting as a separate classand any such act or transaction entered into without such consent or vote shall be null and void ab initio, and of no force or effect: (a) Create, or authorize the creation of, or issue or obligate itself to issue shares of, or reclassify, any material change capital stock unless the same ranks junior to the business scopePreferred Shares with respect to its rights, preferences and privileges, or nature increase the authorized number of shares of Preferred Shares or any additional class or series of capital stock of the business of any Group CompanyCompany unless the same ranks junior to the Preferred Shares with respect to its rights, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group Companypreferences and privileges; (b) any liquidationCreate, dissolution or winding up authorize the creation of, or issue, or authorize the issuance of any Group Companydebt security or create any lien or security interest (except for the Debt Facilities and purchase money liens or statutory liens of landlords, any consummation of a Liquidation Event mechanics, materialmen, workmen, warehousemen and other similar persons arising or effecting any other merger or consolidation; (c) any sale, transfer, license, pledge or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted incurred in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, or any issuance, distribution, purchase or redemption of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (e) any amendment of Restated Articles or other charter documents of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares and the Series A Preferred Shares; (f) any change in share reserve under the ESOP (as defined in the Series B Share Purchase Agreement) or any incur other equity incentive, purchase or participation plan indebtedness for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (g) any approval of or adjustments or modification to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any of the Group Companiesborrowed money, including but not limited to the making of any loans or advances, whether directly or indirectlyobligations and contingent obligations under guarantees, or permit any Subsidiary to take any such action with respect to any debt security lien, security interest or other indebtedness for borrowed money, if the provision ratio of any guarantee, indemnity or security for or in connection with any (x) the aggregate indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group CompaniesCompany and its Subsidiaries for borrowed money following such action, inclusive of the Debt Facilities to (y) of the Company’s EBITDA for the twelve consecutive calendar months immediately preceding such calculation exceeds 2.50:1.00; (hc) Purchase or redeem (or permit any action that results in the payment Subsidiary to purchase or declaration of a redeem) or pay or declare any dividend or make any distribution on, any shares of capital stock of the Company other distribution than redemptions of or dividends or distributions on any Ordinary the Preferred Shares or Preferred Sharesas expressly authorized herein; (id) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any of Except for the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees CDM Acquisition (as defined in the Series B Share Securities Purchase Agreement)), directly or indirectly acquire any beneficial ownership (including stock, partnership or limited liability company interests) of or in any a limited liability company, partnership, joint venture, corporation, trust, unincorporated organization or other Person, or any change in compensation loan, advance or capital contribution to any Person or individual or the acquisition of all, or substantially all, of the assets of another Person or individual, or permit any of its subsidiaries so to do, if the aggregate purchase price payable by the Company and its Subsidiaries for such investments, including the maximum potential amount of any employee of any Group Company by more than US$200,000 in a twelve (12) month period; orcontingent consideration, would exceed $5,000,000; (ne) Enter into, renew, extend or be a party to, any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactionstransactions (including, whether directly without limitation, the purchase, sale, lease, transfer or indirectly and whether exchange of property or not by amendmentassets of any kind or the rendering of services of any kind) with any officer, merger, consolidation, scheme of arrangement, amalgamationdirector, or otherwise, shall require the prior written approval employee of the Board Company, or any Affiliate of such individuals (which approval includes other than the approval Company or any of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controllerits wholly-owned Subsidiaries), in each case that would be required to be disclosed pursuant to Item 404 of Regulation S-K under the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies;1933 Act; or (f) the determination amend, alter or repeal any provision of the exercise price for any share options Articles of Incorporation or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any Bylaws of the actions listed aboveCorporation in a manner that adversely affects the special rights, powers and preferences of the Preferred Stock.

Appears in 1 contract

Sources: Securities Purchase Agreement (Creative Realities, Inc.)

Protective Provisions. 7.1. In addition to such other limitations as may be provided in the Restated Articles, for For so long as any Series A the Preferred Shares are outstandingoutstanding represent on a fully converted basis (as adjusted for any share splits, share dividends and the following acts like), one percent (1%) or more of the Group CompaniesCompany’s outstanding Ordinary Shares, whether including for this purpose any Ordinary Shares issuable pursuant to any exercisable or convertible securities, options, warrants or other rights, notwithstanding any provisions to the contrary in a single transaction or series the Company’s Memorandum of related transactionsAssociation and/or the Articles of Association and in addition to any approvals required by the applicable laws of the British Virgin Islands, whether directly or indirectly and whether or not neither the Company nor the Board of Directors shall (by amendment, merger, consolidation, scheme of arrangement, amalgamation, consolidation or otherwise, shall require ) without first obtaining the prior written approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares, voting as a separate classRequired Approval: (a) pay any material change to the business scope, dividend or nature distribution with respect any class of shares of the business of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group Company; (b) consummate any liquidation, dissolution transaction or winding up series of any Group Company, any consummation of related transactions in which the Company is acquired by a Liquidation Event or effecting any other merger or consolidationthird party where the aggregate proceeds for such acquisition are less than US$300,000,000; (c) consummate any sale, transfer, license, pledge transaction or encumbering all or all substantial technology or intellectual property, other series of related transactions in which another entity is acquired by the Company where the aggregate consideration for such entity paid by the Company is greater than non-exclusive licenses granted in the ordinary course of businessUS$16,000,000; (d) any increasealter or change the rights, decrease preferences or cancellation privileges of any authorized series of Preferred Shares so as to affect adversely the rights, preferences or outstanding shares privileges of any Group Company, or any issuance, distribution, purchase or redemption of any such shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (e) any amendment increase or decrease (other than by redemption or conversion) the total number of Restated Articles or other charter documents of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares and the Series A authorized Preferred Shares; (f) authorize or issue, or obligate itself to issue, any change in share reserve under the ESOP (as defined in the Series B Share Purchase Agreement) or shares including any other equity incentiveright or security convertible into or exercisable for any such shares having a preference over, or being pari passu with, any series of Preferred Shares with respect to dividends, liquidation or redemption; (g) redeem, purchase or participation plan for otherwise acquire any Preferred Shares or Ordinary Shares; provided, however, that this restriction shall not apply to (i) the benefit repurchase of any Ordinary Shares from employees, officers, directors, contractorsconsultants or other persons performing services for the Company or any subsidiary pursuant to agreements under which the Company has the option to repurchase such shares upon the occurrence of certain events, advisors such as the termination of employment or consultants service, or pursuant to a right of first refusal or (ii) the redemption of any of the Group Companies; (g) any approval of or adjustments or modification to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or Preferred Share in connection accordance with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companiesparagraph 10A(3); (h) any action that results in amend the payment or declaration Memorandum of a dividend or other distribution on any Ordinary Shares or Preferred Shares;Association and Articles of Association of the Company; or (i) any merger, consolidation or amalgamation change the authorized number of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any directors of the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed above.

Appears in 1 contract

Sources: Share Purchase Agreement (Longtop Financial Technologies LTD)

Protective Provisions. 7.1. In addition to such other limitations as may be provided in the Restated Memorandum and Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group CompaniesCompany, whether in by operation of a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, reorganization or otherwise, shall require the prior written approval of Preferred Majority, and in the holders of at least two-thirds (2/3) event that any such act set forth below is, by the Companies Law of the then outstanding Series A Cayman Islands (as amended) and every statutory modification or re-enactment thereof for the time being in effect, required to be determined by shareholders of the Company, the consent of the Preferred Shares, voting as Majority shall be deemed obtained if the act is approved at a separate class: (a) any material change to general meeting of the business scopeCompany with the affirmative vote of the Preferred Majority, or nature by way of a written resolution signed by the business Preferred Majority (the term “Company” means, for the purpose of this Section 7, the Company itself as well as any other Group Company, engagement in to the extent and where applicable): (i) any alteration or investment in amendment to the Memorandum and Articles, this Agreement or any new line or business or sale, disposal or cessation of any existing business line other constitutional documents of any Group Company; (bii) any liquidationaction that increases, dissolution reduces or winding up cancels the authorized number of any Group class or series of shares of the Company, any consummation or the number of a Liquidation Event or effecting any other merger or consolidation; (c) any sale, transfer, license, pledge or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares issued share capital of any Group Company, or that authorizes, creates, issues, or repurchases, redeems, or retires any issuance, distribution, purchase or redemption of any shares, shares or securities convertible into or carrying a right of subscription in respect of any shares or any warrant share warrants, or grant or issue any options, warrants, or rights which may require the issue of shares in the future, or any grant other action which has the effect of diluting or reducing the effective shareholding of the Investors in the Company, with the exception of the issuance of options Series D-2 Preferred Shares as contemplated under the Series D-2 Purchase Agreement; (iii) any termination, amendment or waiver of the series of documents through which the PRC Subsidiary acquires the control of the other PRC companies; (iv) any sale, pledge, transfer, disposal or dilution of the Company’s direct or indirect equity interests in any other Group Company; (v) any approval of transfer of shares or equity interests in any Group Company (other than pursuant to an equity incentive plan approved transfer of shares of the Company by the Board, including each Series A Director then in office, if anyany Preferred Holders permitted by Section 4.10); (evi) any amendment of Restated Articles termination or other charter documents suspension of, or material change to the principal business of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares and the Series A Preferred Sharesas currently conducted; (fvii) any distribution of profits amongst the shareholders by way of dividend (interim or otherwise), capitalization of reserves or otherwise, and any change in share reserve under of profit distribution policy; (viii) any increase or decrease of the ESOP (as defined in authorized size of the Series B Share Purchase Agreement) Board or the board of any Group Company or a committee thereof, or any amendment of the rules for appointing directors or committee members as provided herein; (ix) the adoption, amendment or termination of the employee share incentive plan, or other equity incentive, purchase purchase, or participation plan plans for the benefit of any employees, officers, directors, contractors, advisors or consultants of any Group Company, any issuance thereunder, and any increase of the Group Companiestotal number of equity securities reserved for issuance thereunder; (gx) the appointment or removal of the auditors of any Group Company, or any change in the accounting and financial policies or the fiscal year of the Company; (xi) any approval transaction(s) out of the ordinary course of business of any Group Company, with value in excess of RMB3,000,000 individually or adjustments or modification RMB15,000,000 in the aggregate through a series of related transactions during any fiscal year, whether as to the terms incurrence of any transaction involving the interest of any director, employee, officer, management member capital commitment or shareholder of any of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectlycapital expenditure, or the provision purchase or acquisition or lease of any guaranteeassets or real property, indemnity or security for or otherwise; provided, however, any amount contained in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder the annual budget duly approved by the Board shall not be included in the calculation of the Group Companies; (hamount threshold in this Section 7(xii). For the avoidance of doubt, any transaction(s) any action that results in out of the payment or declaration ordinary course of a dividend or other distribution on any Ordinary Shares or Preferred Shares; (i) any merger, consolidation or amalgamation business of any Group Company with that is within the amount contained in such annual budget shall not be subject to this Section 7(xii); (xii) incurrence of indebtedness of any borrowed money or obtaining any financial facilities, or the extension of any loan or advance, or guarantee for indebtedness to, any other entity or entities person other than to a Group Company, provided that the amount of any aforesaid transaction exceeds RMB10,000,000 individually or in the aggregate through a series of related transactions during any fiscal year; (xiii) any creation, issuance or incurrence of any indemnity, debenture, security interest, lien, charge or other encumbrance on all or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any part of the foregoingbusiness, assets or other forms of restructuring rights of any Group Company; (jxiv) any creationsale, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance transfer or other security) on disposal of all or any a part of the business, goodwill or assets or rights out of the ordinary course of business of any Group Company exceeding US$1,000,000 and in excess of RMB10,000,000 of any Group Company, or any license or authorization to third party or other disposal of any business operation right or intellectual property or technology (except for the licenses or its equivalent in another currency or currencies) authorizations which already existed as at the date hereof and as set forth in the aggregate Disclosure Schedule of the Series D-2 Purchase Agreement or are necessary or mandatory in any financial year for the ordinary course of business) owned by any Group Company; (kxv) any initial public offering consolidation or merger with or into any other business entity, the liquidation, dissolution, restructuring, bankruptcy, winding up or initiation of any equity securities similar proceedings of any Group Company; determination , or application for the appointment of the listing venuea receiver, timingmanager, valuation and other terms of the initial public offeringjudicial manager or officer with similar functions, or any action that results in any Trade Sale (as defined below); (lxvi) any acquisition approval of or any investment in change to terms of any transaction between any Group Company and any director, officer, employee or making shareholder of any capital commitment Group Company or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year Affiliate of any of them, except for those transactions between any Group Company and the Group CompaniesZimi Communication Technology (Jiangsu) Co., other than pursuant Ltd. (紫米通讯技术(江苏)有限公司) or the Jiangsu Zimi Electronic Technology Co., Ltd. (江苏紫米电子技术有限公司)in relation to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees Principal Business (as defined in the Series B Share D-2 Purchase Agreement))) with an amount lower than US$6,200,000, or conducted in arms-length in the ordinary course of business of such Group Company, provided that entering into any change in compensation of any employee of contract or arrangement that contains provisions on exclusivity or similar rights restricting any Group Company by to conduct its Principal Business shall require the prior written approval of the holders of more than US$200,000 in a twelve fifty percent (1250%) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), issued and if the Shareholders vote in favor of such act but the approval of outstanding Ordinary Shares and the holders of at least two-thirds (2/3) of the then issued and outstanding Series A Preferred Shares (voting as a single class on an as-converted basis) (which, for avoidance of doubt, shall include the Preferred Majority); (xvii) any investment in excess of RMB3,000,000 individually or RMB15,000,000 in the aggregate through a series of related transactions during any fiscal year in any other entities, or the establishment of any brands for companies other than the Group Companies. Notwithstanding of the foregoing, Alibaba’s consent shall not be required for any investment of less than RMB10,000,000 individually or less than RMB20,000,000 in the aggregate through a series of related transactions during any fiscal year in any other entities, provided, however, that prior to such action being taken, the Company shall, and the Founder Parties shall procure that the Company shall, consult Alibaba in good faith regarding the same; (xviii) any purchase or leasing of real property by the Company in excess of RMB15,000,000 individually or in the aggregate through a series of related transactions during any fiscal year; provided, however, any amount contained in the annual budget duly approved by the Board shall not be included in the calculation of the amount threshold in this Section 7(xix). For the avoidance of doubt, any purchase or leasing of real property by the Company that is within the amount contained in such annual budget shall not be subject to this Section 7(xix); (xix) adoption or amendment of the Company’s annual business plan, annual budget or annual final accounts. Notwithstanding of the foregoing, Alibaba’s consent shall not be required for adoption or amendment of the Company’s annual business plan or annual budget, provided, however, that prior to such action being taken, the Company shall, and the Founder Parties shall procure that the Company shall, consult Alibaba in good faith regarding the same; (xx) establishment of any joint venture, partnership with any third party, establishment of, winding up or sale of any subsidiary that is not wholly owned by any Group Company. Notwithstanding of the foregoing, Alibaba’s consent shall not be required for establishment of any joint venture, partnership with any third party, establishment of, winding up or sale of any subsidiary that is not wholly owned by any Group Company with a total investment of less than RMB10,000,000 individually or less than RMB20,000,000 in the aggregate (through a series of related transactions during any fiscal year), provided, however, that prior to such action being taken, the Company shall, and the Founder Parties shall procure that the Company shall, consult Alibaba in good faith regarding the same; (xxi) initiate, waive, compromise or settle any dispute, claim, litigation or arbitration involving claims of more than RMB5,000,000; (xxii) any amendment or change of the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of the Preferred Shares; (xxiii) appointment or change of underwriters, accountants, legal counsels or listing securities exchanges of the public offering of the equity securities of the Company, or approval of the valuation or scheme of the public offering of the equity securities of the Company. Notwithstanding anything to the contrary contained herein, where any act listed in clauses (i) through (xxiv) requires the approval of the shareholders of the Company in accordance with the Companies Law of the Cayman Islands (as amended) and every statutory modification or re-enactment thereof for the time being in effect, if the shareholders vote in favor of such act but the approval of the Preferred Majority has not yet been obtained, then the holders of then outstanding Series A the Preferred Shares, Shares who voted vote against such Special Resolution act at a meeting of the shareholders in aggregate shall together carry 34% have the voting rights equal to the aggregate voting power of all the shareholders who voted in favor of such act plus one. After the completion of the votes on such Special Resolution with such votes being divided equally among such holders Qualified Public Offering, the protective provisions set forth in this Section 7 shall be automatically terminated, and the Company shall follow the provisions of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations Statute (as may be provided defined in the Restated Memorandum and Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed abovethen effective Memorandum and Articles.

Appears in 1 contract

Sources: Shareholder Agreement (Smart Share Global LTD)

Protective Provisions. 7.1. In addition So long as 2,966,666 shares of Series 1 Preferred Stock are outstanding (subject to such adjustment for stock dividends, splits or combinations or other limitations as recapitalizations), the Corporation shall not without first obtaining the approval, by vote or written consent (which consent need not be unanimous and may be provided in the Restated Articlesobtained without a shareholders' meeting), for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the holders of at least two-thirds (2/3) a majority of the then outstanding shares of Series A 1 Preferred Shares, voting as a separate classStock: (a) authorize any material change to the business scopevoluntary liquidation under applicable bankruptcy legislation, any dissolution, liquidation or nature winding up of the business Corporation or any deemed dissolution, liquidation or winding up within the meaning of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group CompanySection 3(b); (b) effect or taking any liquidation, dissolution action to facilitate any transaction or winding up series of any Group Company, any consummation transactions resulting in the disposition of a Liquidation Event or effecting any other merger or consolidationmore than 50% of the voting power of the Corporation; (c) authorize any salemerger, transfer, license, pledge acquisition or encumbering all consolidation with any other corporation or all substantial technology or intellectual property, other than non-exclusive licenses granted joint venture involving consideration (determined in the ordinary course accordance with Section 3(c)) in excess of business$5,000,000; (d) declare or pay any increase, decrease dividends or cancellation of any authorized other distributions on the Corporation's capital stock (other than a dividend payable solely in shares in Common Stock or outstanding shares of any Group Company, a dividend accruing pursuant to Section 2(b) hereof) or any issuance, distributionredeem, purchase or redemption otherwise acquire any share or shares of any shares, or securities convertible into or carrying a right of subscription Preferred Stock (except as provided in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (e) any amendment of Restated Articles or other charter documents of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares and the Series A Preferred Shares; (f) any change in share reserve under the ESOP (as defined in the Series B Share Purchase AgreementSection 4) or any other equity incentiveCommon Stock; provided, purchase or participation plan for however, that this restriction shall apply neither to the benefit repurchase of any shares of Common Stock from employees, officers, directors, contractorsconsultants or other persons performing services for the Corporation or any subsidiary pursuant to agreements under which the Corporation has the option to repurchase such shares at cost or at cost upon the occurrence of certain events, advisors such as the termination of employment; (e) permit any subsidiary to issue and sell securities having a fair market value (as determined in accordance with Section 3(c)) in excess of $5,000,000; (f) sell more than $5,000,000 in its assets in a single or consultants series of related transactions or create or suffer to be imposed any lien, mortgage, security interest or other charge on or against more than $5,000,000 of the Group Companiesassets; (g) any approval of or adjustments or modification to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with incur any indebtedness or liabilities for borrowed money in excess of any director, employee, officer, management member or shareholder of the Group Companies$5,000,000 in aggregate principal amount; (h) redeem, purchase or otherwise acquire any action that results indebtedness of the Corporation (unless such indebtedness is otherwise due in the payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Sharesaccordance with its terms); (i) authorize any merger, consolidation or amalgamation of any Group Company transactions with any affiliates (other entity or entities or any spinthan wholly-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any owned subsidiaries of the foregoing, or other forms of restructuring of any Group Company;Corporation); or (j) amend or repeal any creationprovision of the Corporation's Articles of Incorporation or Restated Bylaws if such action would adversely affect the relative rights, authorization preferences and privileges of the Series 1 Preferred Stock (including, without limitation, (A) the authorization, creation or issuance of any debenture constituting a pledge, lien Senior Capital Stock or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all Parity Capital Stock or any obligation or security convertible into or exchangeable into, or evidencing a right to purchase, shares of any class or series of Senior Capital Stock or Parity Capital Stock, (B) the increase of the assets directors on the Corporation's Board of Directors to a number greater than 12, or rights (C) the designation and issuance after the Series 1 Purchase Date of any Group additional shares of Series 1 Preferred Stock)." 5. The first paragraph of Exhibit C to the Agreement is amended and restated to read in its entirety as follows: "We have acted as counsel to MedicaLogic/Medscape, Inc., an Oregon corporation (the "Company"), in connection with the sale by the Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the to you of an aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination 5,933,332 shares of the listing venueCompany's Series 1 Convertible Redeemable Preferred Stock, timingwithout par value, valuation and other terms Common Stock Purchase Warrants (the "Warrants") to purchase an aggregate of the initial public offering; (l) any acquisition 4,537,254 shares of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group CompaniesCommon Stock, other than without par value, pursuant to the annual budget Preferred Stock and business plan approved by Warrant Purchase Agreement dated as of December 22, 2000, as amended (the Board, including "Agreement"). This opinion is delivered to you pursuant to Section 4.8 of the affirmative vote Agreement. Capitalized terms not otherwise defined in this opinion shall have the meanings ascribed to them in the Agreement or in the Legal Opinion Accord of each Series A Director then in office, if any;the ABA Section of Business Law (1991) (the "Accord")." (m) any settlement or alteration 6. Recital G of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited Exhibit D to the Key Employees (Agreement is amended and restated to read in its entirety as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed above.follows:

Appears in 1 contract

Sources: Preferred Stock and Warrant Purchase Agreement (Medicalogic/Medscape Inc)

Protective Provisions. 7.1. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares, voting as a separate class: (a) any material change Notwithstanding anything to the business scope, or nature of contrary in the business Constitutional Documents of any Group Company, engagement the parties hereto shall ensure that none of the Group Companies shall, whether directly or indirectly, take any of the actions described below unless Approved by the Series B Holders: (i) any amendment to, cancellation, waiver or other change in respect of, the rights, preferences, privileges, powers, obligations or investment liabilities arising in connection with the Series B Preferred Shares or otherwise adversely affecting the holders thereof; (ii) any new line increase or business decrease in the authorized number of Series B Preferred Shares; (iii) the creation, or saleauthorization of shares, disposal securities or cessation instruments convertible, exchangeable or exercisable for or into shares (including convertible debt), having rights, privileges or preferences superior to or on parity with the Series B Preferred Shares with respect to voting, dividends, redemption, conversion or liquidation or any other rights (including and without limitation, registration rights); (iv) the purchase or redemption of, payment or declaration of any existing business line dividend on, or making of any distribution on, any equity interest therein, other than (i) redemption of the Series B Preferred Shares as expressly authorized herein, (ii) dividends or other distributions payable on the Ordinary Shares solely in the form of additional Ordinary Shares, (iii) upon termination of such services, repurchases of shares at below cost from former employees, officers, directors, consultants or other persons who performed services for any Group Company as permitted by the terms of their engagement by such Group Company approved by the Board, and (iv) repurchases of equity securities by the Company pursuant to Section 9; (v) amendment, alteration or repeal of any provision of the Constitutional Documents of the Company; (bvi) any liquidation, dissolution or winding up of the business and affairs thereof; (vii) any Deemed Liquidation Event; (viii) the issuance or agreement to issue shares or other securities or instruments exchangeable, convertible or exercisable for any equity interest therein other than the Reserved Shares and shares issuable under the Transaction Documents and the Share Option Plan; (ix) raising or authorization of any indebtedness or debt financing by the Company, and the raising or authorization of any indebtedness or debt financing by any other member of the Group if after such indebtedness or debt financing the aggregate amount of indebtedness and debt financing by all members of the Group would exceed US$20 million, provided that this clause (ix) shall not apply to any loan extended to a Group Company by a shareholder of the Company if (i) such loan is made on terms no less favorable to the Group Company than the terms that would be customary in an arms-length loan extended by a commercial bank, (ii) such loan is subordinate to any amounts that are or may become payable to any Investor by the Group Company, whether by virtue of the Investor’s ownership of securities of the Company or pursuant to any of the Transaction Documents, including without limitation any indemnification by the Company pursuant to the Series B Purchase Agreement, and (iii) after receipt of such loan, the aggregate amount of all such loans from shareholders of the Company to the Group Companies does not exceed US$15 million; (x) any increase or decrease in the number of positions on the Board; (xi) the adoption or termination of any Share Option Plan or amendment to any provision of any Share Option Plan or increase in the amount of Ordinary Shares reserved for future issuance pursuant to any Share Option Plan; (xii) any action that effects a reclassification or recapitalization of the issued and outstanding shares of the Company; (xiii) except as specifically contemplated in the Series B Purchase Agreement, the entry into any transaction or series of transactions (or the termination, extension, continuation after expiry, renewal, amendment, variation or waiver of any term under agreement with respect to any transaction or series of transactions) between any Group Company, on the one hand, and any consummation Related Party of a Liquidation Event or effecting any Group Company (other merger or consolidationthan another Group Company), on the other hand; (cxiv) any the sale, transfer, licenselease, pledge assignment, parting with or encumbering all disposal by the Company or all substantial technology or intellectual property, other than non-exclusive licenses granted in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, or any issuance, distribution, purchase or redemption of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (e) any amendment of Restated Articles or other charter documents of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares and the Series A Preferred Shares; (f) any change in share reserve under the ESOP (as defined in the Series B Share Purchase Agreement) or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (g) any approval of or adjustments or modification to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, of all or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder substantially all of the property, assets or revenues of the Company or such Group Companies; Company; (hxv) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Shares; (i) any merger, consolidation consolidation, reorganization, or amalgamation of any Group Company with or into any other entity or entities Person or any spin-off, sub-division, scheme of arrangement or other business combination with or into any other transaction of a similar nature or having a similar economic effect as any of the foregoing, or other forms of restructuring of any Group CompanyPerson; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed above.

Appears in 1 contract

Sources: Shareholders Agreement (China Lodging Group, LTD)

Protective Provisions. 7.1. (a) In addition to such any other limitations rights provided by law or as may be provided set forth in the Restated Articles, for so long as any Series A Preferred Shares are outstandingthis Agreement, the following acts affirmative vote or written consent of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of (x) the holders of at least sixty-six and two-thirds percent (66 2/3%) of the then outstanding Series A Preferred SharesUnits, voting together as a separate classClass, and (y) the Super Majority Class C Investors, shall be required in order for the Company, or any Company Subsidiary, whether by merger, consolidation, recapitalization, reorganization or otherwise, to: (ai) any material change to increase or decrease (other than by redemption or conversion, unless provided otherwise herein) the business scope, or nature total number of the business of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group Companyauthorized Class C Units; (bii) amend, alter, waive, change or repeal any liquidationprovision of, dissolution or winding up of add any Group Companyprovision to, any consummation of a Liquidation Event this Agreement or effecting any other merger document, that amends, alters, waives, changes or consolidationrepeals any of the material powers, preferences, rights, privileges, or restrictions of the Class C Units; (ciii) amend, alter, waive, change or repeal any saleprovision of, transferor add any provision to, licensethis Agreement or any other document, pledge that amends, alters, waives, changes or encumbering all repeals any of the powers, preferences, rights, privileges, or all substantial restrictions of the Class A Units and/or Class B Units in a manner that adversely effects the Class C Units; (iv) cause or authorize any Company Subsidiary to enter into, amend or modify an exclusive license (including exclusive as to territory) where such Company Subsidiary is the licensee of any products or technology or intellectual property, of a third party other than non-exclusive complementary technology related to such Company Subsidiary’s existing products in development or licenses granted in which the Company Subsidiary is the licensee in the ordinary course of businessbusiness consistent with past practice; (dv) cause or authorize any increaseCompany Subsidiary to enter into, decrease amend or cancellation modify a license where such Company Subsidiary is the licensor of any authorized products or outstanding technology, other than a license from which the proceeds are (x) used to further the development of the product that is the subject of the license or (y) distributed to the Unitholders in accordance with Section 7.02; (vi) acquire the capital stock or assets of any other Entity; (vii) increase or decrease the number of Representatives constituting the Board; (viii) issue or otherwise sell shares of capital stock of a Subsidiary to a party other than the Company; (ix) pay or declare any Group dividend or distribution on any Class A Units or Class B Units, or apply any of its assets to the redemption, retirement, purchase or acquisition of Class A Units or Class B Units (except as expressly authorized herein); (x) consent to do any of the foregoing; or (xi) amend, revise, alter or otherwise change any of the foregoing provisions. (b) In addition to any other rights provided by law or as set forth in this Agreement, the affirmative vote or written consent of (x) the holders of at least sixty-six and two-thirds percent (66 2/3%) of the then outstanding Preferred Units, voting together as a Class, and (y) the Majority Class C Investors, shall be required in order for the Company, or any issuanceCompany Subsidiary, distributionwhether by merger, consolidation, recapitalization, reorganization or otherwise, to: (i) authorize or issue or otherwise offer, sell or designate any new or existing Class or Classes of Units or Interests whether having any preference or priority or ranking superior to, junior to or on parity as to distributions, liquidation, redemption, conversion, registration rights, voting or assets with any such preference or priority of the Preferred Units, or authorize or issue Units of any Class or any bonds, debentures, notes or other obligations convertible into or exchangeable for, or having option rights to purchase, any Units of the Company having any preference or priority or ranking superior to, junior to or on parity as to dividends, liquidation, conversion, registration rights, voting or assets superior to, junior to or on a parity with any such preference or priority of the Preferred Units; (ii) pay or declare any dividend or distribution on any Units or Interests (other than the Preferred Units as expressly authorized herein), or apply any of its assets to the redemption, retirement, purchase or redemption acquisition, directly or indirectly, through Subsidiaries or otherwise, of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options Units (other than the Preferred Units as expressly authorized herein), except for (x) repurchases of Units from former employees, directors, or consultants upon termination of any such individual’s relationship with the Company pursuant to an equity incentive plan the terms of such individual’s unit purchase agreement(s) or unit restriction agreement(s) providing for such repurchases at the original issuance prices for such Units, or (y) any right of first refusal granted to the Company by any purchasers of its Units or Interests, if and as approved by the Board, including each Series A Director then in office, if any)affirmative vote or written consent of the Majority Class C Investors; (eiii) any amendment increase or decrease (other than by redemption or conversion, unless provided otherwise herein) the total number of Restated Articles or other charter documents authorized Units of any Group Company which alters Class of Units; (iv) amend, alter, waive, change or adversely affects repeal any provision of, or add any provision to, this Agreement or add any provision to any document that amends, alters, waives, changes or repeals any of the powers, preferences, rights, privileges, or restrictions of the Preferred Units; (v) amend, alter, waive, change or repeal any of the rights, preferences, preferences or privileges or powers of, or of the restrictions provided for the benefit of, the Series B Preferred Shares and the Series A Preferred SharesUnits of any Class thereof; (fvi) sell, or exclusively license or otherwise dispose of all or substantially all of the Company’s or any change Subsidiary’s assets or effect a Subsidiary Sale; (vii) merge or consolidate into, reorganize with, effect a share exchange with, sell to or enter into any other transaction with any other Person or Entity that results in share reserve the holders of the Company’s Units prior to the transaction owning less than fifty percent (50%) of the voting power of the Company’s or other resulting Entity’s equity interests after the transaction or otherwise effect a Company Sale or a transaction that would constitute a Dissolution Event; (viii) except to the extent covered by Section 3.06(a)(v), cause or authorize any Company Subsidiary to enter into, amend or modify an exclusive license (including exclusive as to territory), partnership, strategic alliance, exclusive technology licensing arrangement (including exclusive as to territory) or other corporate partnering relationships other than licenses in which the Company Subsidiary is the licensee in the ordinary course of business consistent with past practice; (ix) enter into a strategic alliance, technology licensing arrangement or other corporate partnering relationship involving the issuance by the Company of Units or Interests; (x) increase the number of Common Units authorized for issuance under the ESOP Option Plan, other than an increase of up to 1,695,000 Common Units in connection with the Second Tranche Closing (as defined in the Series B Share Purchase Agreement); (xi) file, or cause or authorize any Company Subsidiary to file, any Registration Statement with the SEC or authorize any Public Offering other equity incentivethan a Qualified Public Offering; (xii) borrow, purchase or participation plan cause or authorize any Company Subsidiary to borrow, funds or incur indebtedness for the benefit money borrowed in excess of any employees, officers, directors, contractors, advisors or consultants of $500,000; (xiii) consent to do any of the Group Companies;foregoing; or (gxiv) any approval of amend, revise, alter or adjustments or modification to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of otherwise change any of the Group Companiesforegoing provisions. (c) In addition to any other rights provided by law or as set forth in this Agreement, including but not limited to the making affirmative vote or written consent of any loans or advancesthe holders of majority of the then outstanding Class B ▇▇▇▇▇, voting separately as a Class, shall be required in order for the Company, whether directly by merger, consolidation or indirectlyotherwise, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Shares or Preferred Shares;to: (i) amend, alter, waive, change or repeal any provision of this Agreement or add any provision to this Agreement that amends, alters, waives, changes or repeals any of the powers, preferences, rights, privileges, or restrictions of the Class B Units; (ii) increase or decrease (other than by redemption or conversion, unless provided otherwise herein) the total number of authorized Class B units; or (iii) amend, revise, alter or otherwise change any of the provisions included in this Section 3.06(c). (d) In addition to any other rights provided by law or as set forth in this Agreement, the affirmative vote or written consent of the holders of majority of the then outstanding Class A Units, voting separately as a Class, shall be required in order for the Company, whether by merger, consolidation or amalgamation otherwise, to: (i) amend, alter, waive, change or repeal any provision of this Agreement or add any Group Company with provision to any other entity such documents that amends, alters, waives, changes or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as repeals any of the foregoingpowers, preferences, rights, privileges, or other forms restrictions of restructuring of any Group Companythe Class A Units; (jii) any creation, authorization increase or issuance of any debenture constituting a pledge, lien or charge decrease (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to by redemption or conversion, unless provided otherwise herein the annual budget and business plan approved by the Board, including the affirmative vote total number of each Series authorized Class A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month periodUnits; or (niii) any appointmentamend, removalrevise, replacement of the directors of any Group Company; For the avoidance of doubt, if alter or otherwise change any of the foregoing matters requires provisions included in this Section 3.06(d). (e) In addition to any other rights provided by law or as set forth in this Agreement, the approval by way affirmative vote or written consent of the holders of a Special Resolution majority of the then outstanding Units, voting together as a single Class, as well as the affirmative vote or written consent of each (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of i) the holders of at least sixty-six and two-thirds percent (66 2/3%) of the then outstanding Series A Preferred Shares has not been obtainedUnits, then voting together as a Class, and (ii) the holders of then outstanding Series A Preferred SharesMajority Class C Investors, who voted against such Special Resolution at a meeting of shall be required in order for the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group CompaniesCompany, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, consolidation or otherwise, shall require to increase or decrease the prior written approval total number of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed aboveauthorized Common Units.

Appears in 1 contract

Sources: Limited Liability Company Agreement (Cempra Holdings, LLC)

Protective Provisions. 7.1. In addition to such other limitations as may be provided in Except for the Restated Articlesdesignation and issuance of the Company’s Series A, for which is being designated contemporaneously with the Series B, so long as any shares of Series A Preferred Shares B are outstanding, the following acts of Company shall not without first obtaining the Group Companiesapproval (by vote or written consent, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not as provided by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval law) of the holders of at least twoseventy-thirds five percent (2/375%) of the then outstanding shares of Series A Preferred SharesB, voting as a separate class: (a) in any material change manner authorize, issue or create (by reclassification or otherwise) any new class or series of shares having rights, preferences or privileges equal or senior to the business scope, or nature of the business of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group CompanySeries B; (b) any liquidationadversely alter or change the rights, dissolution preferences, designations or winding up privileges of any Group Company, any consummation of a Liquidation Event or effecting any other merger or consolidationthe Series B; (c) any sale, transfer, license, pledge amend the Company’s Articles of Incorporation or encumbering all or all substantial technology or intellectual property, other than nonBy-exclusive licenses granted laws in the ordinary course of business; (d) any increase, decrease or cancellation of any authorized or outstanding shares of any Group Company, or any issuance, distribution, purchase or redemption of any shares, or securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if any); (e) any amendment of Restated Articles or other charter documents of any Group Company which alters or manner that adversely affects the rights, preferences, designations or privileges or powers of, or of the restrictions provided for the benefit of, holders of the Series B Preferred Shares and the Series A Preferred SharesB; (fd) any change in share reserve under increase or decrease the ESOP authorized number of shares of preferred stock of the Company or otherwise reclassify the Company's outstanding securities; (as defined in the Series B Share Purchase Agreemente) or any other equity incentiveredeem, purchase or participation plan otherwise acquire (or pay into or set funds aside for a sinking fund for such purpose) any share or shares of preferred stock or Common Stock; provided, however, that this restriction shall not apply to the benefit de minimus repurchases of any shares of Common Stock from employees, officers, directors, contractorsconsultants or other persons performing services for the Company or any subsidiary pursuant to agreements under which the Company has the option to repurchase such shares at cost upon the occurrence of certain events, advisors such as the termination of employment, or consultants through the exercise of any right of the Group Companies; (g) first refusal; and provided further that this restriction shall not apply to any approval of or adjustments or modification to the terms of any transaction involving the interest of any directorconversion, employee, officer, management member or shareholder of any of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a dividend redemption or other distribution on any Ordinary Shares or Preferred Shares; (i) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any of the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of shares of Series B pursuant to this Certificate of Designations or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than Series A pursuant to the annual budget Certificate of Designations, Preferences and business plan approved by the Board, including the affirmative vote Rights of each Series A Director then in office, if any; (m) any settlement or alteration Convertible Preferred Stock of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month periodCompany; or (nf) any appointmentvoluntarily file for bankruptcy, removal, replacement of liquidate the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction ’s assets or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan make an assignment for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) to authorize, approve or enter into any agreement or obligation with respect to any of the actions listed aboveCompany’s creditors.

Appears in 1 contract

Sources: Series a Convertible Preferred Stock Purchase Agreement (Victory Divide Mining CO)

Protective Provisions. 7.1. In addition to such other limitations as may be provided in During the Restated ArticlesInvestor Rights Period, for so long as Company shall not, and shall not permit any Series A Preferred Shares are outstandingof its subsidiaries to, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether either directly or indirectly and whether or not indirectly, by amendment, merger, consolidation, scheme of arrangementdomestication, amalgamationtransfer, continuance, reorganization, recapitalization, reclassification, waiver, statutory conversion or otherwise, shall require the prior written approval effect any of the holders of at least two-thirds following acts or transactions without (2/3in addition to any other vote required by law or the Governing Documents) the written consent or affirmative vote of the then outstanding Series A Preferred Shares, voting as a separate classLead Purchaser: (a) any material alter or change to the business scope, or nature special rights and restrictions of the business of any Group Company, engagement in or investment in any new line or business or sale, disposal or cessation of any existing business line of any Group CompanyPreferred Shares; (b) any liquidation, dissolution increase or winding up decrease the authorized number of any Group Company, any consummation of a Liquidation Event or effecting any other merger or consolidationPreferred Shares; (c) create (by classification or otherwise) any salenew class or series of shares of capital stock or issue any equity or equity-like instrument resulting in or having rights, transfer, license, pledge preferences or encumbering all or all substantial technology or intellectual property, other than non-exclusive licenses granted privileges in priority to the ordinary course of businessPreferred Shares; (d) redeem or repurchase any increase, decrease securities of the Company or cancellation of any authorized set aside assets for a sinking or outstanding shares of any Group Company, or any issuance, distribution, other similar fund for the purchase or redemption of any shares, or such securities convertible into or carrying a right of subscription in respect of any shares or any warrant or any grant or issuance of options (other than the forfeiture or repurchase of stock from former employees, officers, directors or consultants of the Company in connection with the cessation of such employment or service pursuant to an equity incentive plan approved by the Board, including each Series A Director then in office, if anyterms of existing written agreements with such individuals); (e) amend, modify, alter or repeal any amendment provision of Restated Articles or other charter documents the Governing Documents in a manner adverse to the holders of any Group Company which alters or adversely affects the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of, the Series B Preferred Shares and the Series A Preferred Shares; (f) any change in share reserve under amend the ESOP (as defined in special rights and restrictions of the Series B Share Purchase Agreement) Common Shares or any other equity incentive, purchase or participation plan for the benefit class of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (g) any approval of or adjustments or modification securities junior to the terms of any transaction involving the interest of any director, employee, officer, management member or shareholder of any of the Group Companies, including but not limited to the making of any loans or advances, whether directly or indirectly, or the provision of any guarantee, indemnity or security for or in connection with any indebtedness or liabilities of any director, employee, officer, management member or shareholder of the Group Companies; (h) any action that results in the payment or declaration of a dividend or other distribution on any Ordinary Preferred Shares or Preferred Shares; (i) any merger, consolidation or amalgamation of any Group Company with any other entity or entities or any spin-off, sub-division, or any other transaction of a similar nature or having a similar economic effect as any of the foregoing, or other forms of restructuring of any Group Company; (j) any creation, authorization or issuance of any debenture constituting a pledge, lien or charge (whether by way of fixed or floating charge, mortgage encumbrance or other security) on all or any of the assets or rights of any Group Company exceeding US$1,000,000 (or its equivalent in another currency or currencies) in the aggregate in any financial year for any Group Company; (k) any initial public offering of any equity securities of any Group Company; determination of the listing venue, timing, valuation and other terms of the initial public offering; (l) any acquisition of or any investment in or making any capital commitment or expenditure in excess of US$2,000,000 (or its equivalent in other currency or currencies) in aggregate in any financial year of any of the Group Companies, other than pursuant to the annual budget and business plan approved by the Board, including the affirmative vote of each Series A Director then in office, if any; (m) any settlement or alteration of any employment agreement, salaries, bonuses or other incentive plans of any key management (including but not limited to the Key Employees (as defined in the Series B Share Purchase Agreement)), or any change in compensation of any employee of any Group Company by more than US$200,000 in a twelve (12) month period; or (n) any appointment, removal, replacement of the directors of any Group Company; For the avoidance of doubt, if any of the foregoing matters requires the approval by way of a Special Resolution (as defined in the Restated Articles), and if the Shareholders vote in favor of such act but the approval of manner adverse to the holders of at least two-thirds (2/3) of the then outstanding Series A Preferred Shares has not been obtained, then the holders of then outstanding Series A Preferred Shares, who voted against such Special Resolution at a meeting of the shareholders shall together carry 34% of the votes on such Special Resolution with such votes being divided equally among such holders of the then outstanding Series A Preferred Shares. 7.2. In addition to such other limitations as may be provided in the Restated Articles, for so long as any Series A Preferred Shares are outstanding, the following acts of the Group Companies, whether in a single transaction or series of related transactions, whether directly or indirectly and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, shall require the prior written approval of the Board (which approval includes the approval of each Series A Director then in office, if any, whose approval shall not be unreasonably withheld, delayed or conditioned): (a) any appointment or change of the auditors, accounting policies, internal controls over financial reporting or the financial year of any Group Company; (b) any appointment, removal, replacement of the chief executive officer, the president, the chief financial officer (or financial vice president or financial controller), the chief technology officer and the chief operating officer of any Group Company, including approving any option plans; (c) any approval or material amendment to the annual accounts or budget or business or operating plan of any of the Group Companies, including the capital expenditure plan; (d) any equity investment or entering into any joint venture with any person; (e) the adoption, amendment or termination of the ESOP or any other equity incentive, purchase or participation plan for the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; (f) the determination of the exercise price for any share options or other equity incentives; or (g) any action by a Group Company (if applicable) agree to, commit, resolve to authorize, approve or otherwise enter into any agreement or obligation with respect to do any of the actions listed aboveforegoing.

Appears in 1 contract

Sources: Investor Rights Agreement (Edesa Biotech, Inc.)